"sample_name"	"unique_patient_ID"	"alt_sample_name"	"sample_type"	"primarysite"	"summarygrade"	"G"	"summarystage"	"T"	"N"	"M"	"Dstage"	"age_at_initial_pathologic_diagnosis"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"family_history"	"msi"	"location"	"summarylocation"	"gender"	"kras"	"braf"	"line1"	"tumor_size"	"mutation_apc"	"lymphnodesremoved"	"lymphnodesinvaded"	"stageall"	"ethnicity"	"dfs_status"	"days_to_recurrence_or_death"	"disease_specific_mortality"	"batch"	"drug_name"	"drug_treatment"	"drug_response"	"preop_drug_treatment"	"preop_drug_name"	"fu"	"bevacizumab"	"irinotecan"	"cetuximab"	"capecitabine"	"dexamethasone"	"gcsf"	"fudr"	"folfiri"	"folfox"	"leucovorin"	"mitomycin"	"platin"	"panitumumab"	"pegfilgrastim"	"raltitrexed"	"ancillary"	"chemotherapy"	"moltherapy"	"uncurated_author_metadata"
"TCGA-A6-2684-01A-01R-1410-07"	"TCGA-A6-2684"	"TCGA-A6-2684-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	75	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	33	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 75///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 49929108-023e-4d35-b26d-50ab4d3ae581///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -27708///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 163///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 33///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 2684///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 70.1///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: a2305654-87da-4065-ba07-a491bdefd6d9///date_of_form_completion: 2011-1-24///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 387///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-2684-01A-01R-1410-07///unique_patient_id: TCGA-A6-2684"
"TCGA-A6-2682-01A-01R-1410-07"	"TCGA-A6-2682"	"TCGA-A6-2682-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"1"	NA	70	381	"recurrence"	424	"deceased"	NA	NA	"caecum"	"r"	"m"	"mutant"	NA	NA	NA	NA	13	2	"4"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 70///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 77a44132-af22-4115-9fa2-78f2f74bf687///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25682///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 180///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: 12///kras_mutation_found: YES///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T4b///pathologic_stage: Stage IV///patient_id: 2682///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 96.5///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 9a6eede3-4bca-4aab-afad-6f2fe8c79211///date_of_form_completion: 2011-2-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 424///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: 381///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: DECEASED///Extract.Name: TCGA-A6-2682-01A-01R-1410-07///unique_patient_id: TCGA-A6-2682"
"TCGA-AA-3495-01A-01R-1410-07"	"TCGA-AA-3495"	"TCGA-AA-3495-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	79	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	18	0	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 79///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 15b987ba-77ab-477b-a54a-65ec5c7c399e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28886///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3495///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2002///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3495-01A-01R-1410-07///unique_patient_id: TCGA-AA-3495"
"TCGA-AA-3492-01A-01R-1410-07"	"TCGA-AA-3492"	"TCGA-AA-3492-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	90	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	21	0	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 90///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 85e95dda-6198-464a-9187-fd0832bebb72///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -32872///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3492///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2002///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3492-01A-01R-1410-07///unique_patient_id: TCGA-AA-3492"
"TCGA-A6-2685-01A-01R-1410-07"	"TCGA-A6-2685"	"TCGA-A6-2685-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	48	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	29	0	NA	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 48///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: e5921d6b-51cf-44be-b295-610cf7c3a69a///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -17756///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 171///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 29///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: NA///patient_id: 2685///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 29.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 77.3///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 061b693d-55d3-4f32-8a1e-0c6c107ce80c///date_of_form_completion: 2011-2-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 464///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-2685-01A-01R-1410-07///unique_patient_id: TCGA-A6-2685"
"TCGA-AA-3502-01A-01R-1410-07"	"TCGA-AA-3502"	"TCGA-AA-3502-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	73	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	31	0	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 8368d745-c74d-4236-ba75-16ca7aaeb3ca///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26724///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 31///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3502///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 3.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2003///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3502-01A-01R-1410-07///unique_patient_id: TCGA-AA-3502"
"TCGA-AA-3506-01A-01R-1410-07"	"TCGA-AA-3506"	"TCGA-AA-3506-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	77	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	46	0	"1"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 28033279-cc74-4775-afdf-2497f6ddb55c///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28274///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 46///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 3506///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.08///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2004///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3506-01A-01R-1410-07///unique_patient_id: TCGA-AA-3506"
"TCGA-AZ-4614-01A-01R-1410-07"	"TCGA-AZ-4614"	"TCGA-AZ-4614-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"1"	NA	71	NA	"norecurrence"	172	"deceased"	NA	NA	NA	NA	"f"	NA	NA	NA	NA	NA	4	2	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 71///anatomic_neoplasm_subdivision: NA///b_symptoms: NA///bcr_patient_uuid: 3334201d-a3c0-45ec-a9ed-cf48cc8c38e8///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26267///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 4///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T4a///pathologic_stage: Stage IVA///patient_id: 4614///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 49.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: NA///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: 70///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 2dfe3fab-275b-44f2-a179-cd71f09078c1///date_of_form_completion: 2011-12-30///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 172///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-AZ-4614-01A-01R-1410-07///unique_patient_id: TCGA-AZ-4614"
"TCGA-AZ-4313-01A-01R-1410-07"	"TCGA-AZ-4313"	"TCGA-AZ-4313-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"1"	"0"	"0"	NA	51	NA	"norecurrence"	NA	"living"	NA	NA	"descending"	"l"	"f"	NA	NA	NA	NA	NA	13	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 51///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: 1fd75c4d-e74c-410c-a150-814722c6c1cc///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: 12///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -18764///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T1///pathologic_stage: Stage I///patient_id: 4313///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 5.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: NA///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: 57///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 645fd1e4-91f1-4aac-816c-6846831bd5ce///date_of_form_completion: 2011-12-29///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1532///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-AZ-4313-01A-01R-1410-07///unique_patient_id: TCGA-AZ-4313"
"TCGA-AZ-4315-01A-01R-1410-07"	"TCGA-AZ-4315"	"TCGA-AZ-4315-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	61	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	0	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 61///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: de287a25-981d-49f8-81af-fe0300e4cd31///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: 5///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22340///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 0///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 4315///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: NA///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: NO///weight: 84///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: d385c440-824e-4c54-b439-999e2a62ffed///date_of_form_completion: 2011-12-29///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1776///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-AZ-4315-01A-01R-1410-07///unique_patient_id: TCGA-AZ-4315"
"TCGA-AZ-4684-01A-01R-1410-07"	"TCGA-AZ-4684"	"TCGA-AZ-4684-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	49	411	"recurrence"	1977	"living"	NA	NA	NA	NA	"m"	NA	NA	NA	NA	NA	12	10	"4"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 49///anatomic_neoplasm_subdivision: NA///b_symptoms: NA///bcr_patient_uuid: cac80259-3a26-4a99-b0d3-13454068e6ed///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: 34///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -18252///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 10///number_of_lymphnodes_positive_by_ihc: 10///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IVA///patient_id: 4684///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 8.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: NA///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: NA///weight: 94///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: 6fd93547-1428-44dd-a46a-42c1afdb9de0///date_of_form_completion: 2011-12-30///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1977///days_to_new_tumor_event_after_initial_treatment: 411///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: Liver///targeted_molecular_therapy: NO///vital_status: LIVING///Extract.Name: TCGA-AZ-4684-01A-01R-1410-07///unique_patient_id: TCGA-AZ-4684"
"TCGA-AZ-4615-01A-01R-1410-07"	"TCGA-AZ-4615"	"TCGA-AZ-4615-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	84	688	"norecurrence"	1002	"living"	NA	NA	NA	NA	"m"	"wt"	NA	NA	NA	NA	18	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: NA///b_symptoms: NA///bcr_patient_uuid: bf69a4ce-ec7e-4752-a86d-dcc80e3c9a57///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: 50///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30908///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 170///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 4615///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: NA///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: 84///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: c0630af6-c2eb-4c0b-8452-cbb1963a40ee///date_of_form_completion: 2011-12-30///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1002///days_to_new_tumor_event_after_initial_treatment: 688///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: Liver///targeted_molecular_therapy: YES///vital_status: LIVING///Extract.Name: TCGA-AZ-4615-01A-01R-1410-07///unique_patient_id: TCGA-AZ-4615"
"TCGA-CK-4951-01A-01R-1410-07"	"TCGA-CK-4951"	"TCGA-CK-4951-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	79	479	"recurrence"	2134	"deceased"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	30	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 79///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 2db3c23d-c591-4ea0-b0a8-ed9c4343c80e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 72///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -28982///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 30///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 4951///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 6.2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R1///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: YES///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: a69b950d-1420-422a-8c0a-3ab468e37ffd///date_of_form_completion: 2011-3-29///days_to_additional_surgery_locoregional_procedure: 479///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 2134///days_to_last_followup: 2134///days_to_new_tumor_event_after_initial_treatment: 479///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-CK-4951-01A-01R-1410-07///unique_patient_id: TCGA-CK-4951"
"TCGA-CM-4747-01A-01R-1410-07"	"TCGA-CM-4747"	"TCGA-CM-4747-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"1"	NA	47	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	29	2	"4"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 47///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 56eb96a4-d2c2-42fb-b26c-1a80012bcb8e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -17197///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 188///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Not Expressed|PMS2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 29///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1a///pathologic_N: N1b///pathologic_T: T4a///pathologic_stage: Stage IVA///patient_id: 4747///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 2.6///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 76.7///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: YES///bcr_followup_uuid: e121c355-89bf-4272-9209-0956fc04b7cb///date_of_form_completion: 2010-12-23///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: 61///days_to_death: NA///days_to_last_followup: 244///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: Liver///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-4747-01A-01R-1410-07///unique_patient_id: TCGA-CM-4747"
"TCGA-AA-3509-01A-01R-1410-07"	"TCGA-AA-3509"	"TCGA-AA-3509-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	54	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	27	0	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 54///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 80e677b1-5ebe-4069-a1a5-1538ffee6642///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -19786///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 27///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3509///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.82///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3509-01A-01R-1410-07///unique_patient_id: TCGA-AA-3509"
"TCGA-CA-5256-01A-01R-1410-07"	"TCGA-CA-5256"	"TCGA-CA-5256-01A-01R-1410-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	54	NA	"norecurrence"	NA	"living"	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 54///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 17633a60-e12b-4a7c-bd8a-c16341ddc606///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -19785///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 160///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5256///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: CA///tumor_tissue_site: Colon///venous_invasion: NA///weight: 52///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 72a4c2f9-52a8-49c8-835e-8357415506f3///date_of_form_completion: 2012-1-9///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 65///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CA-5256-01A-01R-1410-07///unique_patient_id: TCGA-CA-5256"
"TCGA-G4-6626-01A-11R-1774-07"	"TCGA-G4-6626"	"TCGA-G4-6626-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	90	NA	"norecurrence"	1422	"deceased"	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	16	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 90///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 3aae5316-6a5d-4b83-9020-ad691d4edf99///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -32872///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6626///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 59///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 4a594724-3caa-46df-8191-ee10cf41514c///date_of_form_completion: 2012-2-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 1422///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-G4-6626-01A-11R-1774-07///unique_patient_id: TCGA-G4-6626"
"TCGA-G4-6625-01A-21R-1774-07"	"TCGA-G4-6625"	"TCGA-G4-6625-01A-21R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	77	2564	"recurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	18	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 5eed7e8a-c219-4497-a99f-bfc48faca4d8///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -28163///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 149///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6625///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 5.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 65.5///year_of_initial_pathologic_diagnosis: 2004///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: YES///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 055b44fa-ba11-4899-984d-01306fe1c57d///date_of_form_completion: 2012-2-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 2791///days_to_new_tumor_event_after_initial_treatment: 2564///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-G4-6625-01A-21R-1774-07///unique_patient_id: TCGA-G4-6625"
"TCGA-G4-6588-01A-11R-1774-07"	"TCGA-G4-6588"	"TCGA-G4-6588-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	58	NA	"norecurrence"	NA	"living"	NA	"MSI"	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	15	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 58///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 93690a96-421c-4c59-85ba-fa6dd538c721///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21532///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 166///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Not Expressed|MSH6 Expressed///lymph_node_examined_count: 15///lymphatic_invasion: NO///microsatellite_instability: YES///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6588///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.8///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 57///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 5790aa3d-cbd3-4c7f-96db-e2f4dc41252e///date_of_form_completion: 2012-1-31///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 796///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-G4-6588-01A-11R-1774-07///unique_patient_id: TCGA-G4-6588"
"TCGA-G4-6586-01A-11R-1774-07"	"TCGA-G4-6586"	"TCGA-G4-6586-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	73	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	17	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 7570761b-c333-40df-ac8c-9b7f94c58ef9///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -27020///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 152.1///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6586///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: YES///weight: 63.2///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: ca0e57d3-a4db-4194-ab5c-3fd15caa2377///date_of_form_completion: 2012-1-31///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1089///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-G4-6586-01A-11R-1774-07///unique_patient_id: TCGA-G4-6586"
"TCGA-G4-6306-01A-11R-1774-07"	"TCGA-G4-6306"	"TCGA-G4-6306-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	71	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	17	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 71///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 303286c2-bc58-4bbb-9171-74cdb1d7f62f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 15///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -26163///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 170///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage IIA///patient_id: 6306///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NA///weight: 110///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: c46277c9-79be-4a2a-9a00-542f8f9ccc9e///date_of_form_completion: 2012-1-23///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1358///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-G4-6306-01A-11R-1774-07///unique_patient_id: TCGA-G4-6306"
"TCGA-F4-6570-01A-11R-1774-07"	"TCGA-F4-6570"	"TCGA-F4-6570-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	78	NA	"norecurrence"	187	"deceased"	NA	NA	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	16	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: eeb42912-0c7a-46bb-bd95-369b2b425727///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28772///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 159///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6570///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 59///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 2BFF0D84-1719-401B-9A98-83D0477A9CD7///date_of_form_completion: 2012-3-29///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 187///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-F4-6570-01A-11R-1774-07///unique_patient_id: TCGA-F4-6570"
"TCGA-F4-6569-01A-11R-1774-07"	"TCGA-F4-6569"	"TCGA-F4-6569-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	60	NA	"norecurrence"	NA	"living"	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	19	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: d3062aac-4c42-41b4-a9f3-90aa72e6fb1e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22203///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 180///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6569///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 60///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: BBB2FCC3-A627-4B43-8AE4-EFF5AFC25D8B///date_of_form_completion: 2012-3-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 408///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-F4-6569-01A-11R-1774-07///unique_patient_id: TCGA-F4-6569"
"TCGA-F4-6461-01A-11R-1774-07"	"TCGA-F4-6461"	"TCGA-F4-6461-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"0"	NA	41	287	"recurrence"	338	"deceased"	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	5	5	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 41///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 2900eadd-7e27-4371-94e5-7d58cdff0138///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -15151///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 151///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 5///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N2///pathologic_T: T4b///pathologic_stage: Stage IIIC///patient_id: 6461///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 57///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 4B99A840-611B-4FF1-880C-E1E3FBA76407///date_of_form_completion: 2012-3-29///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 338///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: 287///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-F4-6461-01A-11R-1774-07///unique_patient_id: TCGA-F4-6461"
"TCGA-F4-6460-01A-11R-1774-07"	"TCGA-F4-6460"	"TCGA-F4-6460-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	51	313	"recurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	6	1	"3"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 51///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 2a7bbafe-d499-4241-ba3d-a52ba0a5db3c///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -18637///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 168///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 6///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6460///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 73///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: C5664BD6-77BB-4B54-95E7-0253119610DE///date_of_form_completion: 2012-3-29///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 407///days_to_new_tumor_event_after_initial_treatment: 313///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: Liver///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-F4-6460-01A-11R-1774-07///unique_patient_id: TCGA-F4-6460"
"TCGA-F4-6459-01A-11R-1774-07"	"TCGA-F4-6459"	"TCGA-F4-6459-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	61	NA	"norecurrence"	261	"deceased"	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	6	6	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 61///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 9fd08502-355b-4f5a-a25c-73ec7184f6d3///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -22574///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 162///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 6///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 6///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N2a///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6459///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 55///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 05EBC8EB-FA35-4BE4-9E17-29A5F91E2AA7///date_of_form_completion: 2012-3-29///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 261///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-F4-6459-01A-11R-1774-07///unique_patient_id: TCGA-F4-6459"
"TCGA-CM-6676-01A-11R-1839-07"	"TCGA-CM-6676"	"TCGA-CM-6676-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	82	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	17	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 4138aca8-e085-45fb-b353-74852efe61bf///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -30223///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 165///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 1///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6676///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 4.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 100///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 3ff9508c-cf0d-4e75-b505-ca17face6a1b///date_of_form_completion: 2012-4-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 337///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6676-01A-11R-1839-07///unique_patient_id: TCGA-CM-6676"
"TCGA-CM-6674-01A-11R-1839-07"	"TCGA-CM-6674"	"TCGA-CM-6674-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	39	NA	"norecurrence"	NA	"living"	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	43	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 39///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 55697871-b9aa-4acd-8dbe-dcd5391db8f0///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -14368///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 167///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Not Expressed|PMS2 Expressed|MSH6 Not Expressed///lymph_node_examined_count: 43///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6674///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 80.7///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 56045152-a712-4509-bd94-59c74eb23c8f///date_of_form_completion: 2012-4-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 394///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6674-01A-11R-1839-07///unique_patient_id: TCGA-CM-6674"
"TCGA-CM-5863-01A-21R-1839-07"	"TCGA-CM-5863"	"TCGA-CM-5863-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	60	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	12	3	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: cc1d6ad3-b60d-482e-8fa4-0af26823007d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -22126///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 150///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1b///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 5863///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 4.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: YES///weight: 103.4///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 7341218e-f244-48e9-873d-be4a48fe079f///date_of_form_completion: 2012-1-16///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 457///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-5863-01A-21R-1839-07///unique_patient_id: TCGA-CM-5863"
"TCGA-CM-4751-01A-02R-1839-07"	"TCGA-CM-4751"	"TCGA-CM-4751-01A-02R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	62	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	48	3	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 62///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: e3ca9046-9634-4332-b19f-88b18110f941///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -22890///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 183///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 48///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1b///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 4751///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 4.2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: YES///weight: 115///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 1fae9028-35a5-42dc-878d-02b34e17e449///date_of_form_completion: 2011-8-8///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 607///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-4751-01A-02R-1839-07///unique_patient_id: TCGA-CM-4751"
"TCGA-CK-6751-01A-11R-1839-07"	"TCGA-CK-6751"	"TCGA-CK-6751-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"2"	"0"	"X"	NA	88	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 88///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 7a70f061-9a6f-408e-a416-7f5295ceba3b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -32353///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6751///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.3///primary_lymph_node_presentation_assessment: NA///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2002///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: bd6e9673-e145-4c90-9fd5-3c2a1d9854c4///date_of_form_completion: 2011-8-00///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 3775///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CK-6751-01A-11R-1839-07///unique_patient_id: TCGA-CK-6751"
"TCGA-CK-6748-01A-11R-1839-07"	"TCGA-CK-6748"	"TCGA-CK-6748-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	45	NA	"norecurrence"	NA	"living"	NA	"MSS"	"sigmoid"	"l"	"f"	"mutant"	NA	NA	NA	NA	NA	NA	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 45///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 8a84b03a-e37e-4827-98f0-4d480ec31037///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 26///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -16529///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: 12///kras_mutation_found: YES///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: 10///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 6748///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 400.26///primary_lymph_node_presentation_assessment: NA///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 7c6318a3-89f9-4a1e-a49c-6a4c2c6c2f4d///date_of_form_completion: 2011-8-00///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CK-6748-01A-11R-1839-07///unique_patient_id: TCGA-CK-6748"
"TCGA-CK-6747-01A-11R-1839-07"	"TCGA-CK-6747"	"TCGA-CK-6747-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"0"	"X"	NA	87	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 87///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 755d3bde-76c3-45c1-8427-8e4d5d686dc1///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -32052///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6747///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 0.9///primary_lymph_node_presentation_assessment: NA///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: e2810946-304a-4ae0-b2f6-d635d2a87d08///date_of_form_completion: 2011-8-00///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CK-6747-01A-11R-1839-07///unique_patient_id: TCGA-CK-6747"
"TCGA-CK-6746-01A-11R-1839-07"	"TCGA-CK-6746"	"TCGA-CK-6746-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"4"	"0"	"X"	NA	84	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: a6f98ee5-9638-4ebe-804b-fba54aea9f90///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 20///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -30957///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|PMS2 Expressed///lymph_node_examined_count: NA///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T4b///pathologic_stage: Stage IIB///patient_id: 6746///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NA///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 1befcb0c-afb7-40c0-b4ae-cb5807cabcab///date_of_form_completion: 2011-8-00///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CK-6746-01A-11R-1839-07///unique_patient_id: TCGA-CK-6746"
"TCGA-CA-6718-01A-11R-1839-07"	"TCGA-CA-6718"	"TCGA-CA-6718-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	46	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 46///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: df5ab6cc-6f68-4b6b-95e2-954c6b57ba9c///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -17109///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 168///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 6718///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CA///tumor_tissue_site: Colon///venous_invasion: NA///weight: 63///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-CA-6718-01A-11R-1839-07///unique_patient_id: TCGA-CA-6718"
"TCGA-CA-6717-01A-11R-1839-07"	"TCGA-CA-6717"	"TCGA-CA-6717-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	57	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 57///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 268c01b3-d2ce-44c0-a2fe-ea846a1253cc///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -20984///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 168///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 6717///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CA///tumor_tissue_site: Colon///venous_invasion: NA///weight: 58///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-CA-6717-01A-11R-1839-07///unique_patient_id: TCGA-CA-6717"
"TCGA-CA-6716-01A-11R-1839-07"	"TCGA-CA-6716"	"TCGA-CA-6716-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	65	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 95a54459-3fac-42d5-8ec1-ed66d971d64d///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23943///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 167///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 6716///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CA///tumor_tissue_site: Colon///venous_invasion: NA///weight: 58///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-CA-6716-01A-11R-1839-07///unique_patient_id: TCGA-CA-6716"
"TCGA-CA-6715-01A-21R-1839-07"	"TCGA-CA-6715"	"TCGA-CA-6715-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	63	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 63///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 794131b8-f4be-4f15-b3b9-6f0b10a5a38b///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23075///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 158///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 6715///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CA///tumor_tissue_site: Colon///venous_invasion: NA///weight: 57///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-CA-6715-01A-21R-1839-07///unique_patient_id: TCGA-CA-6715"
"TCGA-CA-5255-01A-11R-1839-07"	"TCGA-CA-5255"	"TCGA-CA-5255-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	45	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 45///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 563d67a1-f1ba-4722-aa2d-9b35b1689468///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -16743///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 172///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 5255///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CA///tumor_tissue_site: Colon///venous_invasion: NA///weight: 56///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: fe0c2965-c0e3-4fff-ae77-bb2cb4cdf1f6///date_of_form_completion: 2012-1-9///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 93///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: YES///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CA-5255-01A-11R-1839-07///unique_patient_id: TCGA-CA-5255"
"TCGA-CA-5254-01A-21R-1839-07"	"TCGA-CA-5254"	"TCGA-CA-5254-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	42	NA	"norecurrence"	NA	"living"	NA	NA	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 42///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 26a41625-4680-47b2-afa9-6a72b148e1c0///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -15414///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 154///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 5254///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CA///tumor_tissue_site: Colon///venous_invasion: NA///weight: 55///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 6de790b5-e912-4c6c-bb3f-419e7299c0b1///date_of_form_completion: 2012-1-9///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 68///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CA-5254-01A-21R-1839-07///unique_patient_id: TCGA-CA-5254"
"TCGA-AZ-6608-01A-11R-1839-07"	"TCGA-AZ-6608"	"TCGA-AZ-6608-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"2"	"1"	"0"	NA	55	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	12	2	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 55///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: f1e6ce83-b4a0-4643-8e8e-a1ef8a158a27///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -20094///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T2///pathologic_stage: Stage IIIA///patient_id: 6608///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 3.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AZ-6608-01A-11R-1839-07///unique_patient_id: TCGA-AZ-6608"
"TCGA-AZ-6606-01A-11R-1839-07"	"TCGA-AZ-6606"	"TCGA-AZ-6606-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"1"	NA	81	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	17	10	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 81///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: c8d6fe73-3504-42a5-9723-e1916fba8208///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29703///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 10///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 6606///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 10.6///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AZ-6606-01A-11R-1839-07///unique_patient_id: TCGA-AZ-6606"
"TCGA-AZ-6605-11A-01R-1839-07"	"TCGA-AZ-6605"	"TCGA-AZ-6605-11A-01R-1839-07"	"adjacentnormal"	"co"	NA	NA	"late"	"4"	"1"	"0"	NA	77	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	22	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 849031de-ac8a-4012-9362-d192512997f1///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28485///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T4///pathologic_stage: Stage IIIB///patient_id: 6605///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AZ-6605-11A-01R-1839-07///unique_patient_id: TCGA-AZ-6605"
"TCGA-AZ-6603-11A-02R-1839-07"	"TCGA-AZ-6603"	"TCGA-AZ-6603-11A-02R-1839-07"	"adjacentnormal"	"co"	NA	NA	"late"	"2"	"1"	"X"	NA	77	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	3	0	NA	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 56d5b0b9-9093-4286-a2c6-7faa9a1680f5///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28423///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 3///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1///pathologic_T: T2///pathologic_stage: NA///patient_id: 6603///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2002///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AZ-6603-11A-02R-1839-07///unique_patient_id: TCGA-AZ-6603"
"TCGA-AZ-6601-11A-01R-1774-07"	"TCGA-AZ-6601"	"TCGA-AZ-6601-11A-01R-1774-07"	"adjacentnormal"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	68	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	11	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 7ad0617e-bc4a-4869-8419-744f04d9b7a3///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -25082///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 162///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 11///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 6601///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 1.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: 59///year_of_initial_pathologic_diagnosis: 2001///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AZ-6601-11A-01R-1774-07///unique_patient_id: TCGA-AZ-6601"
"TCGA-AZ-6600-11A-01R-1774-07"	"TCGA-AZ-6600"	"TCGA-AZ-6600-11A-01R-1774-07"	"adjacentnormal"	"co"	NA	NA	"late"	"4"	"1"	"1"	NA	64	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	10	1	"4"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 64///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: aee20b98-df51-4ead-86cc-0d5f60a74b90///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23581///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 10///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 6600///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 20.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2001///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AZ-6600-11A-01R-1774-07///unique_patient_id: TCGA-AZ-6600"
"TCGA-AZ-6599-01A-11R-1774-07"	"TCGA-AZ-6599"	"TCGA-AZ-6599-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"2"	"0"	"X"	NA	72	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	25	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 72///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: fbb69964-f962-4b89-b59b-dd05f8faf61a///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26438///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 25///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6599///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2001///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AZ-6599-01A-11R-1774-07///unique_patient_id: TCGA-AZ-6599"
"TCGA-AZ-6598-01A-11R-1774-07"	"TCGA-AZ-6598"	"TCGA-AZ-6598-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"0"	"X"	NA	77	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	24	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: a8b4284d-cbbb-43e3-897b-d04af4bfba74///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28182///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 6598///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 7.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2000///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AZ-6598-01A-11R-1774-07///unique_patient_id: TCGA-AZ-6598"
"TCGA-AZ-4616-01A-21R-1839-07"	"TCGA-AZ-4616"	"TCGA-AZ-4616-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	82	NA	"norecurrence"	156	"deceased"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	23	13	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: e703af88-c05f-4d7b-b225-d640e4d1a2a5///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30043///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 23///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 13///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 4616///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 7c0436fc-b486-4981-a45d-a209f91e7e77///date_of_form_completion: 2011-12-30///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 156///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Dead///Extract.Name: TCGA-AZ-4616-01A-21R-1839-07///unique_patient_id: TCGA-AZ-4616"
"TCGA-AZ-4323-01A-21R-1839-07"	"TCGA-AZ-4323"	"TCGA-AZ-4323-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"1"	NA	37	NA	"norecurrence"	43	"deceased"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	30	5	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 37///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: c59d90a6-9cda-426d-b8ea-41f0a87033d5///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -13754///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 30///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 4323///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: NA///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2002///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: d48d2369-d5d1-43a9-bc42-08696d05ce5e///date_of_form_completion: 2011-12-29///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 43///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Dead///Extract.Name: TCGA-AZ-4323-01A-21R-1839-07///unique_patient_id: TCGA-AZ-4323"
"TCGA-AD-6899-01A-11R-1928-07"	"TCGA-AD-6899"	"TCGA-AD-6899-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"X"	NA	84	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	20	17	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: ea923671-3903-4a79-830d-e7e4b1eabab0///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: 1///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -30681///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 175///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 20///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 17///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N2b///pathologic_T: T4a///pathologic_stage: Stage IIIC///patient_id: 6899///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 6.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AD///tumor_tissue_site: Colon///venous_invasion: YES///weight: 62///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AD-6899-01A-11R-1928-07///unique_patient_id: TCGA-AD-6899"
"TCGA-AD-6895-01A-11R-1928-07"	"TCGA-AD-6895"	"TCGA-AD-6895-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"X"	NA	84	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	17	1	NA	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 4f601d7b-8db1-4c6d-9374-21dcd804980d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 1///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -30893///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 170///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: NA///patient_id: 6895///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AD///tumor_tissue_site: Colon///venous_invasion: YES///weight: 68///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AD-6895-01A-11R-1928-07///unique_patient_id: TCGA-AD-6895"
"TCGA-AD-6890-01A-11R-1928-07"	"TCGA-AD-6890"	"TCGA-AD-6890-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"late"	"1"	"0"	"X"	NA	65	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	22	0	NA	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: e8e80df9-e3ba-4dec-b8fc-a5e80d8c6798///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 10///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -23771///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 2///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T1///pathologic_stage: NA///patient_id: 6890///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AD///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AD-6890-01A-11R-1928-07///unique_patient_id: TCGA-AD-6890"
"TCGA-AD-6889-01A-11R-1928-07"	"TCGA-AD-6889"	"TCGA-AD-6889-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	76	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	16	0	"2"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 76///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 955464c8-9c62-430c-87b8-107db5c980a8///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: [Completed]///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6889///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 7.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AD///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AD-6889-01A-11R-1928-07///unique_patient_id: TCGA-AD-6889"
"TCGA-AD-6888-01A-11R-1928-07"	"TCGA-AD-6888"	"TCGA-AD-6888-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"late"	"2"	"X"	"0"	NA	73	NA	NA	NA	NA	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	18	2	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 13eff2e5-e33a-485f-9ba4-8a7ccb3c7528///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 90///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -26845///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 183///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: NX///pathologic_T: T2///pathologic_stage: Stage IIIB///patient_id: 6888///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AD///tumor_tissue_site: Colon///venous_invasion: YES///weight: 96///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AD-6888-01A-11R-1928-07///unique_patient_id: TCGA-AD-6888"
"TCGA-AD-6548-01A-11R-1839-07"	"TCGA-AD-6548"	"TCGA-AD-6548-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	81	NA	NA	NA	NA	NA	NA	"splenicflexure"	"l"	"f"	NA	NA	NA	NA	NA	12	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 81///anatomic_neoplasm_subdivision: Splenic Flexure///b_symptoms: NA///bcr_patient_uuid: c113808a-773f-4179-82d6-9083518404b5///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: 4///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -29769///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 157.5///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6548///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.6///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AD///tumor_tissue_site: Colon///venous_invasion: NA///weight: 78.6///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AD-6548-01A-11R-1839-07///unique_patient_id: TCGA-AD-6548"
"TCGA-AA-3511-11A-01R-1839-07"	"TCGA-AA-3511"	"TCGA-AA-3511-11A-01R-1839-07"	"adjacentnormal"	"co"	NA	NA	"late"	"4"	"0"	"0"	NA	64	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	36	0	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 64///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 93edb105-5dc9-4a4a-9fca-c91f0161fcc7///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23407///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 36///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T4///pathologic_stage: Stage II///patient_id: 3511///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 35.95///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3511-11A-01R-1839-07///unique_patient_id: TCGA-AA-3511"
"TCGA-AA-3496-01A-21R-1839-07"	"TCGA-AA-3496"	"TCGA-AA-3496-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	83	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	23	0	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 83///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 639e1050-088a-48fe-a0ef-4a01a3468cac///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -30438///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 23///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3496///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2002///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3496-01A-21R-1839-07///unique_patient_id: TCGA-AA-3496"
"TCGA-AA-3489-11A-01R-1839-07"	"TCGA-AA-3489"	"TCGA-AA-3489-11A-01R-1839-07"	"adjacentnormal"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	75	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	28	0	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 75///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: b95720b1-aa00-4c6a-b202-3350d035829f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -27605///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 28///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3489///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2002///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3489-11A-01R-1839-07///unique_patient_id: TCGA-AA-3489"
"TCGA-A6-6782-01A-11R-1839-07"	"TCGA-A6-6782"	"TCGA-A6-6782-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"4"	"0"	"X"	NA	82	NA	"norecurrence"	NA	"living"	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	25	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 3eb37b12-b8b4-40a3-bd8b-f89fc39c05fa///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -30011///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 175///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 25///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T4a///pathologic_stage: Stage IIB///patient_id: 6782///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 2.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NA///weight: 63.2///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: ef0e3db6-7ea5-4685-b159-fa133ae9db75///date_of_form_completion: 2012-3-23///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 189///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-6782-01A-11R-1839-07///unique_patient_id: TCGA-A6-6782"
"TCGA-A6-6781-01A-22R-1928-07"	"TCGA-A6-6781"	"TCGA-A6-6781-01A-22R-1928-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"X"	NA	43	NA	"norecurrence"	NA	"living"	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	30	2	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 43///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: b54865b6-824e-4163-b759-21a6eacc98ce///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -15841///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 190.5///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 30///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1b///pathologic_T: T4b///pathologic_stage: Stage IIIC///patient_id: 6781///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 6.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 87.5///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: e8050064-6641-462c-af41-0d85d0c12b58///date_of_form_completion: 2012-3-12///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 293///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-6781-01A-22R-1928-07///unique_patient_id: TCGA-A6-6781"
"TCGA-A6-6780-01A-11R-1839-07"	"TCGA-A6-6780"	"TCGA-A6-6780-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"0"	"X"	NA	74	NA	"norecurrence"	NA	"living"	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	18	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 74///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 88832340-46ad-449c-8f81-6a8e5b495510///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -27250///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 168///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6780///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 64.1///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 9586e98f-8c22-4669-b122-303b77295180///date_of_form_completion: 2012-3-23///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 354///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-6780-01A-11R-1839-07///unique_patient_id: TCGA-A6-6780"
"TCGA-A6-6654-01A-21R-1839-07"	"TCGA-A6-6654"	"TCGA-A6-6654-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	65	NA	"norecurrence"	NA	"living"	NA	"MSS"	"descending"	"l"	"f"	NA	NA	NA	NA	NA	65	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: 81e7cca8-2d71-4446-9692-872c2fe68d0a///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -23953///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 173///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 65///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6654///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 97.4///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 31b87b18-a612-40b9-b2ff-9bd5c7060d6b///date_of_form_completion: 2012-3-22///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 399///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-6654-01A-21R-1839-07///unique_patient_id: TCGA-A6-6654"
"TCGA-A6-6653-01A-11R-1774-07"	"TCGA-A6-6653"	"TCGA-A6-6653-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	82	NA	"norecurrence"	NA	"living"	NA	"MSI"	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	12	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 68801d41-535f-4b38-989b-ef4fe5f00039///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Abnormal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -29996///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 182.8///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Expressed|PMS2 Not Expressed|MSH6 Expressed///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: YES///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 5///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6653///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 98.3///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 0fc8c732-c324-4f90-99ab-3dee80a99ba4///date_of_form_completion: 2012-2-7///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 282///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-6653-01A-11R-1774-07///unique_patient_id: TCGA-A6-6653"
"TCGA-A6-6652-01A-11R-1774-07"	"TCGA-A6-6652"	"TCGA-A6-6652-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"0"	"1"	NA	59	NA	"norecurrence"	NA	"living"	NA	"MSS"	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	22	0	"4"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 59///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 96ac1f4b-79b0-4517-8caf-fc05abcaaf4f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -21638///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 185///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IVA///patient_id: 6652///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 4.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 137.6///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 7a5cef72-d273-467d-92ef-9bef3e3d1d5e///date_of_form_completion: 2012-4-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 455///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-6652-01A-11R-1774-07///unique_patient_id: TCGA-A6-6652"
"TCGA-A6-6651-01A-21R-1839-07"	"TCGA-A6-6651"	"TCGA-A6-6651-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"X"	NA	55	NA	"norecurrence"	NA	"living"	NA	NA	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	33	2	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 55///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 0ec6ed47-db99-4273-9823-ffbde6a77091///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -20110///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 162.6///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 33///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1b///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6651///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 88.5///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: a004938c-4f52-49d0-a40c-d8f5558d23d5///date_of_form_completion: 2011-11-21///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 258///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-6651-01A-21R-1839-07///unique_patient_id: TCGA-A6-6651"
"TCGA-A6-6650-01A-11R-1774-07"	"TCGA-A6-6650"	"TCGA-A6-6650-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	69	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	19	0	"2"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 6cd8d2dd-5545-43b0-b796-ae0506d62eb8///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25516///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 162.6///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6650///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 94.7///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: c0becc9e-7b2a-4c8a-905c-7cf38bf7dcac///date_of_form_completion: 2011-11-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 277///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-6650-01A-11R-1774-07///unique_patient_id: TCGA-A6-6650"
"TCGA-A6-6142-01A-11R-1774-07"	"TCGA-A6-6142"	"TCGA-A6-6142-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	56	NA	"norecurrence"	NA	"living"	NA	"MSS"	"sigmoid"	"l"	"f"	"wt"	NA	NA	NA	NA	37	1	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 56///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: c7c5348f-5708-45bf-b40e-1bf7c9348f60///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -20485///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 162.5///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 37///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1a///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: Stage IVA///patient_id: 6142///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 88///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 03276653-4e71-4c56-8f41-e41b60422ae7///date_of_form_completion: 2012-2-28///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 368///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-6142-01A-11R-1774-07///unique_patient_id: TCGA-A6-6142"
"TCGA-A6-5664-01A-21R-1839-07"	"TCGA-A6-5664"	"TCGA-A6-5664-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"X"	NA	80	183	"recurrence"	NA	"living"	NA	"MSS"	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	18	5	"3"	"black"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: f88c0259-58ff-4bcc-a777-7705cdbd8213///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -29425///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 180.3///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 18///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N2a///pathologic_T: T4a///pathologic_stage: Stage IIIC///patient_id: 5664///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 17.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 70.3///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: 1a788873-317a-4b1c-902b-33fdd6561dba///date_of_form_completion: 2011-8-31///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 362///days_to_new_tumor_event_after_initial_treatment: 183///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-5664-01A-21R-1839-07///unique_patient_id: TCGA-A6-5664"
"TCGA-A6-5656-01A-21R-1839-07"	"TCGA-A6-5656"	"TCGA-A6-5656-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	74	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	16	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 74///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: eb4e4e09-98b3-4e85-8dd2-75676ff2af14///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -27183///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 179///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 5656///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 76.6///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: c53511a6-e362-4ebe-9f2a-229ba56761af///date_of_form_completion: 2011-9-1///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 462///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-5656-01A-21R-1839-07///unique_patient_id: TCGA-A6-5656"
"TCGA-CM-5348-01A-21R-1723-07"	"TCGA-CM-5348"	"TCGA-CM-5348-01A-21R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	72	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	19	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 72///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: b89267a4-0e6b-401e-85b0-e66775858aa6///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -26543///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 163///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 5348///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 3.6///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 85.5///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 9913416a-5d9c-4392-beed-87ca620f40e8///date_of_form_completion: 2012-1-17///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 668///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-5348-01A-21R-1723-07///unique_patient_id: TCGA-CM-5348"
"TCGA-AY-6196-01A-11R-1723-07"	"TCGA-AY-6196"	"TCGA-AY-6196-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	NA	NA	47	NA	NA	NA	"living"	NA	"MSS"	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	14	12	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 47///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 2c30dc20-18a8-44f9-ab10-558c1e5634dc///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -17311///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 14///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 12///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: NA///pathologic_N: N2b///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 6196///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 5.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AY///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 67f6053c-81fe-4190-a695-1dd09993577f///date_of_form_completion: 2012-2-20///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 6///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Alive///Extract.Name: TCGA-AY-6196-01A-11R-1723-07///unique_patient_id: TCGA-AY-6196"
"TCGA-CM-6168-01A-11R-1653-07"	"TCGA-CM-6168"	"TCGA-CM-6168-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	84	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	31	0	"2"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 75c3004d-1ef4-49f9-86e0-1bb7b9553a3d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -30834///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 149///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 31///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6168///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 7.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: YES///weight: 52.5///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: c8e26df1-e523-431e-8652-22c3ecaffda9///date_of_form_completion: 2012-2-13///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 395///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6168-01A-11R-1653-07///unique_patient_id: TCGA-CM-6168"
"TCGA-G4-6302-01A-11R-1723-07"	"TCGA-G4-6302"	"TCGA-G4-6302-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	90	NA	"norecurrence"	2046	"deceased"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	15	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 90///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 7144a65f-a63f-4b79-8fe2-cfe48696de03///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 1///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -32872///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 152.5///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6302///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: YES///weight: 57///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 14156fbf-46da-4770-b3c6-6409bba1da9e///date_of_form_completion: 2012-1-20///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 2046///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-G4-6302-01A-11R-1723-07///unique_patient_id: TCGA-G4-6302"
"TCGA-A6-5667-11A-01R-1723-07"	"TCGA-A6-5667"	"TCGA-A6-5667-11A-01R-1723-07"	"adjacentnormal"	"co"	NA	NA	"late"	"3"	"1"	"X"	NA	40	NA	"norecurrence"	NA	"living"	NA	"MSS"	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	48	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 40///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 28d03569-8717-40da-8989-70baf2b18f9f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -14755///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 175///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 48///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 4///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 5667///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 36.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 76///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 653617e8-af70-4eca-9a56-5c65f4886720///date_of_form_completion: 2011-6-27///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 320///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-5667-11A-01R-1723-07///unique_patient_id: TCGA-A6-5667"
"TCGA-AA-3655-11A-01R-1723-07"	"TCGA-AA-3655"	"TCGA-AA-3655-11A-01R-1723-07"	"adjacentnormal"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	68	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	22	0	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 31a3877d-3e82-450e-811f-3448b06f3950///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24896///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3655///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3655-11A-01R-1723-07///unique_patient_id: TCGA-AA-3655"
"TCGA-F4-6463-01A-11R-1723-07"	"TCGA-F4-6463"	"TCGA-F4-6463-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	51	NA	"norecurrence"	NA	"living"	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	18	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 51///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: cbe23011-93b7-4e9f-b934-bd0122f91f54///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -18804///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 174///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6463///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 62///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: AB1EE0F1-5753-4E0B-B5E0-A6396B494BB3///date_of_form_completion: 2012-3-28///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 414///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-F4-6463-01A-11R-1723-07///unique_patient_id: TCGA-F4-6463"
"TCGA-AA-3663-11A-01R-1723-07"	"TCGA-AA-3663"	"TCGA-AA-3663-11A-01R-1723-07"	"adjacentnormal"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	42	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	40	0	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 42///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: c21d2c68-920f-4526-b754-286579c049f3///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -15675///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 40///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3663///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 18.77///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3663-11A-01R-1723-07///unique_patient_id: TCGA-AA-3663"
"TCGA-G4-6314-01A-11R-1723-07"	"TCGA-G4-6314"	"TCGA-G4-6314-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	76	605	"recurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	"wt"	NA	NA	NA	NA	59	50	"4"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 76///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: abe658e0-33f9-4f57-849b-dec4d20964d6///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -27957///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 158.5///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 59///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 50///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 6314///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: YES///weight: 84.1///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: YES///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: b88cfe5e-3c22-4b28-9ed0-4f3112ab1e85///date_of_form_completion: 2012-2-9///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1093///days_to_new_tumor_event_after_initial_treatment: 605///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6314-01A-11R-1723-07///unique_patient_id: TCGA-G4-6314"
"TCGA-A6-2675-11A-01R-1723-07"	"TCGA-A6-2675"	"TCGA-A6-2675-11A-01R-1723-07"	"adjacentnormal"	"co"	NA	NA	"late"	"3"	"0"	"X"	NA	78	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	11	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 07dc5a1d-64b7-42ba-928e-9753bd533c1e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -28812///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 160///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 11///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 2///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 2675///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 71.3///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: a2ead2c9-c7e6-40a7-9b9e-d0695b739978///date_of_form_completion: 2011-7-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 846///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-2675-11A-01R-1723-07///unique_patient_id: TCGA-A6-2675"
"TCGA-AA-3662-11A-01R-1723-07"	"TCGA-AA-3662"	"TCGA-AA-3662-11A-01R-1723-07"	"adjacentnormal"	"co"	NA	NA	"late"	"4"	"2"	"1"	NA	80	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	15	4	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: d9fb85c3-ade1-47bf-8159-170f81eb130f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29554///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 4///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 3662///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1286///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3662-11A-01R-1723-07///unique_patient_id: TCGA-AA-3662"
"TCGA-G4-6297-01A-11R-1723-07"	"TCGA-G4-6297"	"TCGA-G4-6297-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	55	438	"recurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	36	6	"4"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 55///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 622cc1c4-d721-4b5c-a88b-216d6368660b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -20103///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 36///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 6///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 6297///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: YES///weight: 64///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: e7d3bbc5-fd32-4a46-9f2a-63da9cdb778a///date_of_form_completion: 2012-1-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 2506///days_to_new_tumor_event_after_initial_treatment: 438///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6297-01A-11R-1723-07///unique_patient_id: TCGA-G4-6297"
"TCGA-D5-5541-01A-01R-1653-07"	"TCGA-D5-5541"	"TCGA-D5-5541-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	63	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	8	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 63///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 94067eb7-98b7-4975-bab1-c09e1b454a25///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 36///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -23108///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 170///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 8///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 5541///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 81///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 2de2e12a-db7f-4273-b7b7-ce76fb26a638///date_of_form_completion: 2011-7-4///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 350///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-D5-5541-01A-01R-1653-07///unique_patient_id: TCGA-D5-5541"
"TCGA-AU-6004-01A-11R-1723-07"	"TCGA-AU-6004"	"TCGA-AU-6004-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	69	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	16	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 32b77693-18e1-4692-8488-add1940c9e7c///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 90///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25259///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 160///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6004///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AU///tumor_tissue_site: Colon///venous_invasion: NO///weight: 55///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AU-6004-01A-11R-1723-07///unique_patient_id: TCGA-AU-6004"
"TCGA-CM-5868-01A-01R-1653-07"	"TCGA-CM-5868"	"TCGA-CM-5868-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"1"	NA	59	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"f"	"wt"	NA	NA	NA	NA	17	1	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 59///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 4aadf2a2-ce1e-4f94-b146-59292e83e7fd///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21671///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 171///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1a///pathologic_N: N1a///pathologic_T: T4a///pathologic_stage: Stage IVA///patient_id: 5868///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 93///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: YES///weight: 99.8///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: fb63b396-92b1-4d29-9180-2fec4f7e2bef///date_of_form_completion: 2012-1-16///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 518///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-5868-01A-01R-1653-07///unique_patient_id: TCGA-CM-5868"
"TCGA-AA-3660-01A-01R-1723-07"	"TCGA-AA-3660"	"TCGA-AA-3660-01A-01R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	51	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	33	0	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 51///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: f9b5e6a5-c2da-4a0d-9251-bb6f557b7b58///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -18932///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 33///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 3660///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.37///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3660-01A-01R-1723-07///unique_patient_id: TCGA-AA-3660"
"TCGA-CM-6161-01A-11R-1653-07"	"TCGA-CM-6161"	"TCGA-CM-6161-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	36	NA	"norecurrence"	NA	"living"	NA	"MSS"	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	31	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 36///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 3470b1af-689f-467a-9f9e-de74088f9b94///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -13363///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 174///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Not Expressed|PMS2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 31///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6161///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 0.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 65.6///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: aa74a6c3-e686-4d36-ae77-c35ac4716e96///date_of_form_completion: 2012-2-13///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 457///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6161-01A-11R-1653-07///unique_patient_id: TCGA-CM-6161"
"TCGA-AA-3713-01A-21R-1723-07"	"TCGA-AA-3713"	"TCGA-AA-3713-01A-21R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"0"	"1"	NA	68	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	15	0	"4"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 57a2044d-20cc-4d02-b268-ce570a0fabe3///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24927///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 3713///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 83.68///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: NA///residual_tumor: R2///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3713-01A-21R-1723-07///unique_patient_id: TCGA-AA-3713"
"TCGA-D5-6536-01A-11R-1723-07"	"TCGA-D5-6536"	"TCGA-D5-6536-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	73	493	"recurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	14	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: e83e5700-f968-4978-bb78-56a83936ce8c///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 11///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -26889///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 165///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 14///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6536///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 83///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: YES///additional_surgery_metastatic_procedure: YES///bcr_followup_uuid: 041460eb-afaa-4b47-a417-48b06dddf2f9///date_of_form_completion: 2012-3-2///days_to_additional_surgery_locoregional_procedure: 514///days_to_additional_surgery_metastatic_procedure: 514///days_to_death: NA///days_to_last_followup: 543///days_to_new_tumor_event_after_initial_treatment: 493///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: R2///site_of_additional_surgery_new_tumor_event_mets: Liver///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6536-01A-11R-1723-07///unique_patient_id: TCGA-D5-6536"
"TCGA-CM-5349-01A-21R-1723-07"	"TCGA-CM-5349"	"TCGA-CM-5349-01A-21R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	68	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	21	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 227f945f-76fd-4a63-9609-d4e730a3d22a///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -24867///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 156///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Not Expressed|PMS2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5349///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 54.4///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 368cc1d7-da30-404b-940c-cd5a035c1e2e///date_of_form_completion: 2012-1-17///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 579///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-5349-01A-21R-1723-07///unique_patient_id: TCGA-CM-5349"
"TCGA-A6-5659-01A-01R-1653-07"	"TCGA-A6-5659"	"TCGA-A6-5659-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	82	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	26	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 98d45099-feae-4dad-aa38-ec03fed6d999///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -30027///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 180///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 26///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 5659///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 117.1///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: bf113369-ec1e-411d-bc5c-ade4f54e1811///date_of_form_completion: 2011-5-26///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 286///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-5659-01A-01R-1653-07///unique_patient_id: TCGA-A6-5659"
"TCGA-AU-3779-01A-01R-1723-07"	"TCGA-AU-3779"	"TCGA-AU-3779-01A-01R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	80	NA	NA	NA	NA	NA	"MSS"	"rectosigmoid"	"l"	"f"	NA	NA	NA	NA	NA	21	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Rectosigmoid Junction///b_symptoms: NA///bcr_patient_uuid: fb4cc403-694c-421f-b360-3108b6d57ad5///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 35///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -29460///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 157///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 0///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3779///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AU///tumor_tissue_site: Colon///venous_invasion: NO///weight: 83///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AU-3779-01A-01R-1723-07///unique_patient_id: TCGA-AU-3779"
"TCGA-G4-6311-01A-11R-1723-07"	"TCGA-G4-6311"	"TCGA-G4-6311-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"X"	NA	80	NA	"norecurrence"	NA	"living"	NA	"MSS"	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	37	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 79d33c28-a7e2-4fca-8be1-a16fb6d68d49///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -29296///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 173.5///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 37///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 6311///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 0.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: YES///weight: 69.9///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: fff8f999-e75e-4ceb-881d-eaf85fc19430///date_of_form_completion: 2012-1-27///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1199///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6311-01A-11R-1723-07///unique_patient_id: TCGA-G4-6311"
"TCGA-CM-5344-01A-21R-1723-07"	"TCGA-CM-5344"	"TCGA-CM-5344-01A-21R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	39	NA	"norecurrence"	NA	"living"	NA	"MSS"	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	108	3	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 39///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: b6202d8d-dd3c-4fa2-9242-6e55759846af///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -14425///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 156///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Not Expressed|PMS2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 108///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1b///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 5344///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 1.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 64.9///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 0fe5d114-8fc1-4119-ac74-f898ccfd5152///date_of_form_completion: 2012-1-17///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 488///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-5344-01A-21R-1723-07///unique_patient_id: TCGA-CM-5344"
"TCGA-A6-5660-01A-01R-1653-07"	"TCGA-A6-5660"	"TCGA-A6-5660-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	73	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	23	11	"3"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 0dc41cd5-0672-407c-9b4a-0f5f3970aa54///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -26802///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 170///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 23///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 11///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2b///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 5660///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 0.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 94.4///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 38affb8d-f8ed-4aa8-a42c-edd6bdc795e3///date_of_form_completion: 2011-6-1///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 342///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-5660-01A-01R-1653-07///unique_patient_id: TCGA-A6-5660"
"TCGA-AY-6197-01A-11R-1723-07"	"TCGA-AY-6197"	"TCGA-AY-6197-01A-11R-1723-07"	"tumor"	"co"	NA	NA	NA	"3"	"0"	NA	NA	60	NA	"norecurrence"	NA	"living"	NA	"MSI"	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	16	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: f6c674bf-396d-4bfe-8d08-e7266c314be3///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21957///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: YES///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 4///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: NA///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6197///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AY///tumor_tissue_site: Colon///venous_invasion: NO///weight: 158///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: b801b588-c3a7-4427-a746-a639eb95a134///date_of_form_completion: 2012-2-20///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 423///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-AY-6197-01A-11R-1723-07///unique_patient_id: TCGA-AY-6197"
"TCGA-G4-6293-01A-11R-1723-07"	"TCGA-G4-6293"	"TCGA-G4-6293-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	49	NA	"norecurrence"	NA	"living"	NA	"MSI"	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	26	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 49///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 27d9c162-11bb-48fb-a41a-aa05fcb4c1c2///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -18075///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 150///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 26///lymphatic_invasion: NO///microsatellite_instability: YES///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 6293///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 64.5///year_of_initial_pathologic_diagnosis: 2002///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 38cdb95b-9cce-43d4-b3db-3b0ebc66f744///date_of_form_completion: 2012-1-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 3275///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6293-01A-11R-1723-07///unique_patient_id: TCGA-G4-6293"
"TCGA-D5-6539-01A-11R-1723-07"	"TCGA-D5-6539"	"TCGA-D5-6539-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	45	NA	"norecurrence"	NA	"living"	NA	NA	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	12	0	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 45///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: ef4bb5bf-4535-4bd1-8a74-aba920123ee2///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -16703///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 165///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIIA///patient_id: 6539///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 1.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 63///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 0d71e69a-dd69-4022-92fa-542c7818f224///date_of_form_completion: 2012-3-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 380///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6539-01A-11R-1723-07///unique_patient_id: TCGA-D5-6539"
"TCGA-D5-6535-01A-11R-1723-07"	"TCGA-D5-6535"	"TCGA-D5-6535-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"X"	NA	80	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	6	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: a123dc45-e427-461e-8d60-c51307aa498c///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 1///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -29278///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 157///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 6///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6535///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 66.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 65///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 4c8edf3f-088b-44b8-ac9a-3174e674e754///date_of_form_completion: 2012-3-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 460///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6535-01A-11R-1723-07///unique_patient_id: TCGA-D5-6535"
"TCGA-CK-5913-01A-11R-1653-07"	"TCGA-CK-5913"	"TCGA-CK-5913-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"0"	"X"	NA	58	NA	NA	NA	NA	NA	"MSI"	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 58///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 3758f4f7-ac2f-4f9d-bee2-526196f8129a///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: 2///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21398///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Expressed|PMS2 Not Expressed|MSH6 Expressed///lymph_node_examined_count: NA///lymphatic_invasion: NO///microsatellite_instability: YES///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 9///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: 10///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5913///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 0.6///primary_lymph_node_presentation_assessment: NA///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-CK-5913-01A-11R-1653-07///unique_patient_id: TCGA-CK-5913"
"TCGA-D5-6531-01A-11R-1723-07"	"TCGA-D5-6531"	"TCGA-D5-6531-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	75	NA	"norecurrence"	NA	"living"	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	4	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 75///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: e4c0d890-a634-48bd-9108-e674532b0d2e///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -27632///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 167///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 4///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6531///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: NA///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 60///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: b98f9c34-3631-493a-81d5-b49fe9ffe73f///date_of_form_completion: 2012-2-27///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 540///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6531-01A-11R-1723-07///unique_patient_id: TCGA-D5-6531"
"TCGA-AM-5820-01A-01R-1653-07"	"TCGA-AM-5820"	"TCGA-AM-5820-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"1"	NA	59	NA	NA	NA	NA	NA	"MSS"	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	4	4	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 59///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 26a12266-c6d8-42f9-bd4e-5093d827ac9a///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21901///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 164///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 4///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 4///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T4a///pathologic_stage: Stage IVA///patient_id: 5820///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 176.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 98///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AM-5820-01A-01R-1653-07///unique_patient_id: TCGA-AM-5820"
"TCGA-D5-6538-01A-11R-1723-07"	"TCGA-D5-6538"	"TCGA-D5-6538-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	79	NA	"norecurrence"	NA	"living"	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	14	10	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 79///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: a117ace8-ac5a-48d8-8aee-3024d6f0f873///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -29194///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 152///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 14///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 10///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6538///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 23.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: YES///weight: 57///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 798baee4-cda2-479c-ac27-f84845d43d2d///date_of_form_completion: 2012-2-27///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 521///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-D5-6538-01A-11R-1723-07///unique_patient_id: TCGA-D5-6538"
"TCGA-AY-5543-01A-01R-1653-07"	"TCGA-AY-5543"	"TCGA-AY-5543-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	65	NA	"norecurrence"	NA	"living"	NA	"MSS"	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	24	1	"4"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 14cc6f5b-5692-471e-98b4-ae200b3d8fed///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -23870///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: Stage IVA///patient_id: 5543///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AY///tumor_tissue_site: Colon///venous_invasion: NO///weight: 61.3///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: cf329ba5-376f-4a12-bdac-b79cc97cf52f///date_of_form_completion: 2012-1-4///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 479///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-AY-5543-01A-01R-1653-07///unique_patient_id: TCGA-AY-5543"
"TCGA-D5-6530-01A-11R-1723-07"	"TCGA-D5-6530"	"TCGA-D5-6530-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	53	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	15	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 53///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: f89bbd17-c732-4847-b71c-a8627a702747///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 40///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -19591///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 182///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6530///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 3.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 89///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 810c037c-fbfe-4fd0-9bda-09511085edda///date_of_form_completion: 2012-3-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 621///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6530-01A-11R-1723-07///unique_patient_id: TCGA-D5-6530"
"TCGA-D5-6540-01A-11R-1723-07"	"TCGA-D5-6540"	"TCGA-D5-6540-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	66	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	13	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 66///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: b08b5f49-9434-4653-9772-097ec29b2ca3///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -24282///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 186///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6540///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: NA///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 86///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 3c36a5cb-a781-4214-bd44-b0491edcc689///date_of_form_completion: 2012-2-27///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 491///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6540-01A-11R-1723-07///unique_patient_id: TCGA-D5-6540"
"TCGA-CK-5914-01A-11R-1653-07"	"TCGA-CK-5914"	"TCGA-CK-5914-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"X"	NA	81	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 81///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 57b0f89f-1b75-453e-922c-01cd4d44ca49///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 25///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -29585///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 5914///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NA///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-CK-5914-01A-11R-1653-07///unique_patient_id: TCGA-CK-5914"
"TCGA-D5-6533-01A-11R-1723-07"	"TCGA-D5-6533"	"TCGA-D5-6533-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"4"	"0"	"0"	NA	68	NA	NA	NA	NA	NA	NA	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	8	0	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: fa83dfb5-7386-4a35-9861-aa866478d5f1///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 0///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -24971///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 156///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 8///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T4b///pathologic_stage: Stage IIIB///patient_id: 6533///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 228.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 51///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-D5-6533-01A-11R-1723-07///unique_patient_id: TCGA-D5-6533"
"TCGA-AA-3697-01A-01R-1723-07"	"TCGA-AA-3697"	"TCGA-AA-3697-01A-01R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	77	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	50	0	"3"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: dde411b2-5d2b-4638-8149-89bc1eb3c7ad///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28367///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 50///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 3697///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 4.6///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2003///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3697-01A-01R-1723-07///unique_patient_id: TCGA-AA-3697"
"TCGA-G4-6298-01A-11R-1723-07"	"TCGA-G4-6298"	"TCGA-G4-6298-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"X"	NA	90	291	"recurrence"	715	"deceased"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	37	1	"3"	"black"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 90///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: ab9cc98a-86ae-4913-bcb2-cc3aeff8abb1///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -32872///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 37///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1///pathologic_T: T4a///pathologic_stage: Stage IIIB///patient_id: 6298///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 59.4///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: f60f0d08-60bd-4515-aa39-c364b1163c69///date_of_form_completion: 2012-1-20///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 715///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: 291///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-G4-6298-01A-11R-1723-07///unique_patient_id: TCGA-G4-6298"
"TCGA-G4-6295-01A-11R-1723-07"	"TCGA-G4-6295"	"TCGA-G4-6295-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	70	NA	"norecurrence"	NA	"living"	NA	"MSS"	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	23	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 70///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: e17959bd-045d-4540-b43a-c3863e8ff3c0///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -25757///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 23///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 6295///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 59///year_of_initial_pathologic_diagnosis: 2004///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 98402fef-6ffb-4a00-93a5-76e4ed148257///date_of_form_completion: 2012-1-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 254///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-G4-6295-01A-11R-1723-07///unique_patient_id: TCGA-G4-6295"
"TCGA-D5-6537-01A-11R-1723-07"	"TCGA-D5-6537"	"TCGA-D5-6537-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"X"	NA	64	123	"recurrence"	145	"deceased"	NA	NA	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	11	1	"3"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 64///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: ebc5a6f8-34fd-48c1-a2b9-7f60f45fbf27///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 18///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -23381///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 176///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 11///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6537///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 2.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 80///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: 867db67e-686b-4bfa-97d6-ba7216a534f9///date_of_form_completion: 2012-3-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 145///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: 123///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: Liver///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-D5-6537-01A-11R-1723-07///unique_patient_id: TCGA-D5-6537"
"TCGA-AY-6386-01A-21R-1723-07"	"TCGA-AY-6386"	"TCGA-AY-6386-01A-21R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	66	NA	"norecurrence"	360	"living"	NA	"MSS"	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	19	1	"3"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 66///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 35c9264f-34ec-4d75-ab80-aaac86108fc8///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -24453///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 153///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6386///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AY///tumor_tissue_site: Colon///venous_invasion: NO///weight: 86///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: e09f8b62-6bec-42ff-9f44-7c287ab2d81a///date_of_form_completion: 2012-2-20///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 360///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: LIVING///Extract.Name: TCGA-AY-6386-01A-21R-1723-07///unique_patient_id: TCGA-AY-6386"
"TCGA-G4-6320-01A-11R-1723-07"	"TCGA-G4-6320"	"TCGA-G4-6320-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"X"	NA	73	NA	"norecurrence"	NA	"living"	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	65	2	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: da21e143-dbf6-4ac7-8872-f1d9ae39512d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -26839///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 193///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 65///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage III///patient_id: 6320///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: YES///weight: 139.7///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: cb06e666-d3ef-4c7c-a79a-4c1ac6ab428c///date_of_form_completion: 2012-1-30///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 804///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6320-01A-11R-1723-07///unique_patient_id: TCGA-G4-6320"
"TCGA-G4-6315-01A-11R-1723-07"	"TCGA-G4-6315"	"TCGA-G4-6315-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	66	NA	"norecurrence"	NA	"living"	NA	NA	"descending"	"l"	"m"	"wt"	NA	NA	NA	NA	82	1	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 66///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: ca5b878f-8bff-410a-8e6e-b1c133018c8d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 1///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -24174///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 170///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 82///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 6315///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 43.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 58///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 0f586976-8f4b-451e-b96c-5f998705d12f///date_of_form_completion: 2012-1-27///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1117///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6315-01A-11R-1723-07///unique_patient_id: TCGA-G4-6315"
"TCGA-CK-4952-01A-01R-1723-07"	"TCGA-CK-4952"	"TCGA-CK-4952-01A-01R-1723-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"0"	NA	48	NA	"norecurrence"	NA	"living"	NA	"MSS"	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	31	5	"3"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 48///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 5342e2e8-1465-4f7b-9450-ef27280f80c7///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 21///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -17826///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 31///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: 10///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N2///pathologic_T: T4///pathologic_stage: Stage III///patient_id: 4952///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 112c687f-cc16-4102-a7d3-eaf410addfa1///date_of_form_completion: 2011-3-31///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CK-4952-01A-01R-1723-07///unique_patient_id: TCGA-CK-4952"
"TCGA-CM-5864-01A-01R-1653-07"	"TCGA-CM-5864"	"TCGA-CM-5864-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	60	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	33	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 5b259d18-3976-4f44-967f-fe5fa8447c8b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -22218///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 180///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Not Expressed|PMS2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 33///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 5864///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 103///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 095b83b6-c29b-4b31-80c1-3d8e6d442a4b///date_of_form_completion: 2012-1-16///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 457///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-5864-01A-01R-1653-07///unique_patient_id: TCGA-CM-5864"
"TCGA-CK-5912-01A-11R-1653-07"	"TCGA-CK-5912"	"TCGA-CK-5912-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"late"	"2"	"0"	"X"	NA	82	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 82///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: c085da47-d634-491a-80ea-514e5a231f70///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 140///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -29950///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 5912///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.3///primary_lymph_node_presentation_assessment: NA///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-CK-5912-01A-11R-1653-07///unique_patient_id: TCGA-CK-5912"
"TCGA-G4-6321-01A-11R-1723-07"	"TCGA-G4-6321"	"TCGA-G4-6321-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"2"	"1"	"X"	NA	60	NA	"norecurrence"	NA	"living"	NA	"MSI"	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	44	3	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: e7dbfca1-9657-4952-8e0d-dec6373dda5b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 110///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -21921///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 178.2///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Not Expressed|MSH6 Expressed///lymph_node_examined_count: 44///lymphatic_invasion: NO///microsatellite_instability: YES///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1///pathologic_T: T2///pathologic_stage: Stage III///patient_id: 6321///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 3.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 100///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: fe9a60d5-5c9b-4650-95dd-92820bf57f9f///date_of_form_completion: 2012-1-30///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 671///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6321-01A-11R-1723-07///unique_patient_id: TCGA-G4-6321"
"TCGA-AM-5821-01A-01R-1653-07"	"TCGA-AM-5821"	"TCGA-AM-5821-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	68	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 605baa86-79e3-484d-82d2-4de27d405ba1///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -24903///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 148///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5821///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 68///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AM-5821-01A-01R-1653-07///unique_patient_id: TCGA-AM-5821"
"TCGA-AZ-5407-01A-01R-1723-07"	"TCGA-AZ-5407"	"TCGA-AZ-5407-01A-01R-1723-07"	"tumor"	"co"	NA	NA	"early"	"1"	"0"	"0"	NA	51	NA	"norecurrence"	NA	"living"	NA	"MSS"	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	16	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 51///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: b718134c-5231-4f29-a423-7bad17c93fc5///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -18820///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T1///pathologic_stage: Stage I///patient_id: 5407///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 3c864783-4302-4f29-85eb-edb63028df3d///date_of_form_completion: 2012-5-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1868///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-AZ-5407-01A-01R-1723-07///unique_patient_id: TCGA-AZ-5407"
"TCGA-CM-4743-01A-01R-1723-07"	"TCGA-CM-4743"	"TCGA-CM-4743-01A-01R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	69	NA	"norecurrence"	NA	"living"	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	27	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: c8d7eb0f-2502-4277-a8ef-435b08f3c863///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25290///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 167///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 27///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 4743///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 84.4///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 115cfd38-5ab8-4f5d-abe3-f04bf8655d6a///date_of_form_completion: 2011-1-24///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 184///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-4743-01A-01R-1723-07///unique_patient_id: TCGA-CM-4743"
"TCGA-D5-5540-01A-01R-1653-07"	"TCGA-D5-5540"	"TCGA-D5-5540-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	73	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	12	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 31d960d7-8f5b-4d22-bf5e-fae0849c4efd///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 70///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -26972///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 175///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5540///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 83///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 728155f4-e2fa-49bd-a4d1-7c478bb7215f///date_of_form_completion: 2011-7-4///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 411///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-5540-01A-01R-1653-07///unique_patient_id: TCGA-D5-5540"
"TCGA-G4-6317-01A-11R-1723-07"	"TCGA-G4-6317"	"TCGA-G4-6317-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"X"	NA	51	591	"recurrence"	NA	"living"	NA	"MSS"	"sigmoid"	"l"	"f"	"wt"	NA	NA	NA	NA	109	6	"3"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 51///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: cee553c8-460d-436b-b55d-8f41624816cc///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -18822///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 162///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 109///lymphatic_invasion: NA///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 6///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 6317///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NA///weight: 95.3///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: YES///bcr_followup_uuid: 10c5ef89-d062-465e-a0ed-a8eea2794475///date_of_form_completion: 2012-1-30///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: 620///days_to_death: NA///days_to_last_followup: 1095///days_to_new_tumor_event_after_initial_treatment: 591///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: Liver///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6317-01A-11R-1723-07///unique_patient_id: TCGA-G4-6317"
"TCGA-D5-6534-01A-21R-1928-07"	"TCGA-D5-6534"	"TCGA-D5-6534-01A-21R-1928-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	62	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	22	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 62///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: d259eeb2-d15e-436d-9d37-2d0b7658bc91///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -22777///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 170///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 22///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6534///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 0.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 94///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-D5-6534-01A-21R-1928-07///unique_patient_id: TCGA-D5-6534"
"TCGA-D5-6928-01A-11R-1928-07"	"TCGA-D5-6928"	"TCGA-D5-6928-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	80	NA	"norecurrence"	NA	"living"	NA	"MSS"	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	18	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: eecaa5cd-0b69-4af2-a782-035025f207b6///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 65///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -29411///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 174///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 18///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6928///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 93///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 4379456e-4118-4173-abde-f743c00e081b///date_of_form_completion: 2012-3-28///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 354///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6928-01A-11R-1928-07///unique_patient_id: TCGA-D5-6928"
"TCGA-A6-5662-11A-01R-1653-07"	"TCGA-A6-5662"	"TCGA-A6-5662-11A-01R-1653-07"	"adjacentnormal"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	46	NA	"norecurrence"	NA	"living"	NA	"MSS"	"splenicflexure"	"l"	"m"	"mutant"	NA	NA	NA	NA	13	7	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"y"	"age_at_initial_pathologic_diagnosis: 46///anatomic_neoplasm_subdivision: Splenic Flexure///b_symptoms: NA///bcr_patient_uuid: 960d278c-c87d-42dc-ad28-42e010d8f0f1///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -16873///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 180///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: 12///kras_mutation_found: YES///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 13///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 7///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IVA///patient_id: 5662///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 84.4///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 56638b81-e2a6-41ea-84ca-942a64fe13d4///date_of_form_completion: 2011-11-8///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 453///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-5662-11A-01R-1653-07///unique_patient_id: TCGA-A6-5662"
"TCGA-D5-5539-01A-01R-1653-07"	"TCGA-D5-5539"	"TCGA-D5-5539-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	60	579	"recurrence"	NA	"living"	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	4	1	"3"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 15d1b0fb-5c5f-4689-94f5-b33120a2bfae///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22096///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 168///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 4///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIA///patient_id: 5539///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NA///weight: 83///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: 747a6f16-843f-475d-a1af-3bba604fc855///date_of_form_completion: 2012-1-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 596///days_to_new_tumor_event_after_initial_treatment: 579///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-D5-5539-01A-01R-1653-07///unique_patient_id: TCGA-D5-5539"
"TCGA-CM-6162-01A-11R-1653-07"	"TCGA-CM-6162"	"TCGA-CM-6162-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	48	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	46	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 48///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: ec3f3f11-75df-4fcc-ba03-f19aca907645///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -17624///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 171///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Expressed|PMS2 Not Expressed|MSH6 Expressed///lymph_node_examined_count: 46///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6162///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 1.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: YES///weight: 109///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 10c4783b-e5e8-44d3-889b-dad314a551ff///date_of_form_completion: 2012-2-13///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 365///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-6162-01A-11R-1653-07///unique_patient_id: TCGA-CM-6162"
"TCGA-AD-6901-01A-11R-1928-07"	"TCGA-AD-6901"	"TCGA-AD-6901-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"late"	"3"	"0"	"X"	NA	78	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	19	0	NA	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: b76d1de7-6447-474d-bf67-77e0bb2da73a///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 1///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -28578///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 170///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T3///pathologic_stage: NA///patient_id: 6901///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AD///tumor_tissue_site: Colon///venous_invasion: NO///weight: 69///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AD-6901-01A-11R-1928-07///unique_patient_id: TCGA-AD-6901"
"TCGA-CM-6163-01A-11R-1653-07"	"TCGA-CM-6163"	"TCGA-CM-6163-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"early"	"1"	"0"	"0"	NA	74	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	23	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 74///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 8c043ecd-2265-411f-bc3b-dc341cf56ac2///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -27150///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 179///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 23///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T1///pathologic_stage: Stage I///patient_id: 6163///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 8.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: YES///weight: 75.8///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: b245fa46-9213-4b0e-8ed3-04a9137b94d7///date_of_form_completion: 2011-7-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 90///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6163-01A-11R-1653-07///unique_patient_id: TCGA-CM-6163"
"TCGA-D5-5538-01A-01R-1653-07"	"TCGA-D5-5538"	"TCGA-D5-5538-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	60	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	6	3	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 0dacc5ce-498f-4c60-9f78-7a013ffaa9ce///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 50///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21973///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 165///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 6///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1b///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 5538///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 4.11///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 70///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: b0e0994a-d81f-4ead-be64-788e2950a919///date_of_form_completion: 2011-6-20///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 373///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-D5-5538-01A-01R-1653-07///unique_patient_id: TCGA-D5-5538"
"TCGA-CM-6172-01A-11R-1653-07"	"TCGA-CM-6172"	"TCGA-CM-6172-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	70	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	17	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 70///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 40c217ee-429f-41f4-adc6-db9186622b17///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25902///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 151///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6172///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 77.6///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 7e8f262a-70b0-4400-98d7-1ff14780452a///date_of_form_completion: 2012-2-13///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 334///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-6172-01A-11R-1653-07///unique_patient_id: TCGA-CM-6172"
"TCGA-A6-5665-11A-01R-1653-07"	"TCGA-A6-5665"	"TCGA-A6-5665-11A-01R-1653-07"	"adjacentnormal"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	84	NA	"norecurrence"	NA	"living"	NA	"MSI"	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	25	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 4c6c8d3d-e4a3-490a-9211-cfbe7e6ee25b///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Abnormal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -30914///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 157///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Expressed|PMS2 Not Expressed|MSH6 Expressed///lymph_node_examined_count: 25///lymphatic_invasion: YES///microsatellite_instability: YES///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 5///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5665///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 19///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 90.8///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 3a84dc0c-15e9-4b82-a2b7-32fb24c0c855///date_of_form_completion: 2011-11-1///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 404///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-5665-11A-01R-1653-07///unique_patient_id: TCGA-A6-5665"
"TCGA-D5-6926-01A-11R-1928-07"	"TCGA-D5-6926"	"TCGA-D5-6926-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"0"	NA	65	NA	"norecurrence"	NA	"living"	NA	"MSS"	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	34	3	"3"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 3a8ca50f-bc9f-4250-8c8d-22893763ea46///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -23767///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 175///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 34///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T4a///pathologic_stage: Stage IIIA///patient_id: 6926///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 82///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: ea66d5f0-67f6-4508-a51f-6c3bf90e1f40///date_of_form_completion: 2012-3-26///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 275///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: YES///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-D5-6926-01A-11R-1928-07///unique_patient_id: TCGA-D5-6926"
"TCGA-A6-4105-01A-02R-1774-07"	"TCGA-A6-4105"	"TCGA-A6-4105-01A-02R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	79	NA	"norecurrence"	441	"deceased"	NA	"MSS"	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	19	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 79///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 95d4f0c4-5997-4ffb-b876-0ddfeee972bb///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -29097///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 180.3///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 4105///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 83.3///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 955d7416-0751-4214-bf0e-66d3b0afd770///date_of_form_completion: 2011-6-24///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 441///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: DECEASED///Extract.Name: TCGA-A6-4105-01A-02R-1774-07///unique_patient_id: TCGA-A6-4105"
"TCGA-AD-6964-01A-11R-1928-07"	"TCGA-AD-6964"	"TCGA-AD-6964-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	NA	NA	58	NA	NA	NA	NA	NA	"MSS"	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	16	0	NA	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 58///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 5e7074a6-5011-4dc5-950c-41365dbc6d09///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: 0///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21457///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 183///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Expressed|PMS2 Not Expressed|MSH6 Expressed///lymph_node_examined_count: 16///lymphatic_invasion: YES///microsatellite_instability: NO///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 9///pathologic_M: NA///pathologic_N: N2b///pathologic_T: T4a///pathologic_stage: NA///patient_id: 6964///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AD///tumor_tissue_site: Colon///venous_invasion: YES///weight: 91///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AD-6964-01A-11R-1928-07///unique_patient_id: TCGA-AD-6964"
"TCGA-D5-6924-01A-11R-1928-07"	"TCGA-D5-6924"	"TCGA-D5-6924-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	68	NA	"norecurrence"	NA	"living"	NA	"MSS"	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	8	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 68///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: be85f845-b281-467c-8b97-bed7b7fdff64///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -24964///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 165///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 8///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6924///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 3.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 85///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: f5daaff5-f2bc-42ab-9bda-53dcf1a305d0///date_of_form_completion: 2012-3-30///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 434///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6924-01A-11R-1928-07///unique_patient_id: TCGA-D5-6924"
"TCGA-AD-6965-01A-11R-1928-07"	"TCGA-AD-6965"	"TCGA-AD-6965-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"X"	NA	62	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	17	11	NA	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 62///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: c8de215d-53a4-4e6c-be58-5887a8094815///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22857///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 183///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 11///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N2b///pathologic_T: T4a///pathologic_stage: NA///patient_id: 6965///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AD///tumor_tissue_site: Colon///venous_invasion: YES///weight: 95///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AD-6965-01A-11R-1928-07///unique_patient_id: TCGA-AD-6965"
"TCGA-AZ-5403-01A-01R-1653-07"	"TCGA-AZ-5403"	"TCGA-AZ-5403-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"0"	"X"	NA	43	304	"recurrence"	1910	"deceased"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	12	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 43///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 85a57cfe-f1c9-44d9-8b50-022c0d3438d1///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: 65///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -15983///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage II///patient_id: 5403///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 2.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 5th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2000///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: c08f9325-5b69-41d4-9706-4256f974f1e5///date_of_form_completion: 2012-5-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 1910///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: 304///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-AZ-5403-01A-01R-1653-07///unique_patient_id: TCGA-AZ-5403"
"TCGA-CM-6170-01A-11R-1653-07"	"TCGA-CM-6170"	"TCGA-CM-6170-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	73	NA	"norecurrence"	NA	"living"	NA	NA	"descending"	"l"	"f"	NA	NA	NA	NA	NA	12	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: 9d8c4693-8e36-473b-bb34-a7cdc04dd223///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -26662///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 145///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6170///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 0.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 85.8///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: bbf9aeb6-4a1c-4c62-9471-aed9ead72e26///date_of_form_completion: 2012-2-13///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 457///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6170-01A-11R-1653-07///unique_patient_id: TCGA-CM-6170"
"TCGA-D5-6929-01A-31R-1928-07"	"TCGA-D5-6929"	"TCGA-D5-6929-01A-31R-1928-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	49	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	12	1	"4"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 49///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 64b0461f-038d-4712-948e-818dc2f10eef///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -17919///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 167///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 6929///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 4.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 80///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: AE4CEDC0-70C2-4922-83B7-7E89FD9C9274///date_of_form_completion: 2012-3-30///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 407///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-D5-6929-01A-31R-1928-07///unique_patient_id: TCGA-D5-6929"
"TCGA-CA-5797-01A-01R-1653-07"	"TCGA-CA-5797"	"TCGA-CA-5797-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	56	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	"other"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 56///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 3e0c34cb-fca5-4bcf-a5c1-5a7d286dd072///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -20661///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5797///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: NA///tertiary_pattern: NA///tissue_source_site: CA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 88e5623d-a3a5-45bd-8467-3e0afa361cb6///date_of_form_completion: 2012-1-9///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 100///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CA-5797-01A-01R-1653-07///unique_patient_id: TCGA-CA-5797"
"TCGA-CK-4947-01B-11R-1653-07"	"TCGA-CK-4947"	"TCGA-CK-4947-01B-11R-1653-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"0"	NA	46	31	"recurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	12	3	"4"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 46///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 73f9681a-f9ef-4880-bd16-93624fd117c6///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -16980///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N1///pathologic_T: T4a///pathologic_stage: Stage IVA///patient_id: 4947///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2003///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: dccfb70e-98e2-44e0-b30c-c8fb98e6568a///date_of_form_completion: 2011-3-31///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: 31///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CK-4947-01B-11R-1653-07///unique_patient_id: TCGA-CK-4947"
"TCGA-D5-6930-01A-11R-1928-07"	"TCGA-D5-6930"	"TCGA-D5-6930-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	67	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	20	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 67///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 286cbae3-8324-43b7-9b20-0f40dda1588e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 40///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -24764///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 184///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 20///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6930///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 90///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-D5-6930-01A-11R-1928-07///unique_patient_id: TCGA-D5-6930"
"TCGA-A6-6141-01A-11R-1774-07"	"TCGA-A6-6141"	"TCGA-A6-6141-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	31	NA	"norecurrence"	NA	"living"	NA	"MSS"	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	19	0	"2"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 31///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 58facedb-fcb8-4ecf-8338-2bfa4947acef///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -11391///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 177.8///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6141///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 96.8///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: f0900dfb-dfa3-4d5a-8233-cc0427052f6b///date_of_form_completion: 2012-2-13///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 254///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-6141-01A-11R-1774-07///unique_patient_id: TCGA-A6-6141"
"TCGA-CM-6171-01A-11R-1653-07"	"TCGA-CM-6171"	"TCGA-CM-6171-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	77	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	28	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: eed7405f-f8f3-41a4-a0e7-242f23087f59///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -28307///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 162///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 28///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6171///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 71.2///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 592175ac-cd48-4eb1-908d-05c6895168db///date_of_form_completion: 2012-2-14///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 427///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6171-01A-11R-1653-07///unique_patient_id: TCGA-CM-6171"
"TCGA-A6-6138-01A-11R-1774-07"	"TCGA-A6-6138"	"TCGA-A6-6138-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	61	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	24	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 61///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 4ad9784e-1edc-4186-9b45-4dfe0003f74b///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -22523///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 185.4///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6138///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 90.7///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: ffbc6fdc-d573-42b5-bd3f-bf948012482b///date_of_form_completion: 2011-10-28///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 279///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-6138-01A-11R-1774-07///unique_patient_id: TCGA-A6-6138"
"TCGA-AD-5900-01A-11R-1653-07"	"TCGA-AD-5900"	"TCGA-AD-5900-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"late"	"2"	"0"	"X"	NA	67	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	11	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 67///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 0f008098-d8aa-46dc-8445-cca59838c582///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -24776///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 11///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 5900///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: AD///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AD-5900-01A-11R-1653-07///unique_patient_id: TCGA-AD-5900"
"TCGA-D5-6927-01A-21R-1928-07"	"TCGA-D5-6927"	"TCGA-D5-6927-01A-21R-1928-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	34	NA	"norecurrence"	NA	"living"	NA	"MSS"	"transverse"	"r"	"m"	NA	NA	NA	NA	NA	16	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 34///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: a782f174-241d-42c6-9bc4-61cc39f8b397///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 13///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -12737///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 177///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6927///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 0.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 76///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 3badbc1c-a0fe-42fc-9fb0-504bde8ae2a9///date_of_form_completion: 2012-3-28///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 287///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6927-01A-21R-1928-07///unique_patient_id: TCGA-D5-6927"
"TCGA-D5-5537-01A-21R-1928-07"	"TCGA-D5-5537"	"TCGA-D5-5537-01A-21R-1928-07"	"tumor"	"co"	NA	NA	"late"	"3"	"0"	"X"	NA	83	NA	NA	NA	NA	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	10	7	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 83///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: ae6b315f-3f78-4695-adfa-48b0bbab2c89///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -30504///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 168///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 10///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 7///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIIA///patient_id: 5537///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 75///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-D5-5537-01A-21R-1928-07///unique_patient_id: TCGA-D5-5537"
"TCGA-F4-6855-01A-11R-1928-07"	"TCGA-F4-6855"	"TCGA-F4-6855-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	70	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	12	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 70///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 1c111912-c664-42f5-9802-065b1994a2f4///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25890///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 167///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6855///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 80///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 19B8863F-11ED-497E-8AE0-6CBB16F2CAFC///date_of_form_completion: 2012-5-11///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 300///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-F4-6855-01A-11R-1928-07///unique_patient_id: TCGA-F4-6855"
"TCGA-A6-6140-01A-11R-1774-07"	"TCGA-A6-6140"	"TCGA-A6-6140-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	62	NA	"norecurrence"	NA	"living"	NA	NA	"descending"	"l"	"m"	NA	NA	NA	NA	NA	46	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 62///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: 21ddbfaa-1b21-4a2b-be2c-237dd69b20ff///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -22835///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 177.8///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 46///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6140///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 78.9///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 2d883e40-6e47-469d-996d-6e59563a0f28///date_of_form_completion: 2012-1-16///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 356///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-6140-01A-11R-1774-07///unique_patient_id: TCGA-A6-6140"
"TCGA-CM-5860-01A-01R-1653-07"	"TCGA-CM-5860"	"TCGA-CM-5860-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	44	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	44	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 44///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 96e013d9-8e89-46a7-8d07-bae95af36708///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -16343///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 182///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 44///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5860///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: YES///weight: 100.7///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: fa571d57-01ed-4cc5-8213-535c26012e22///date_of_form_completion: 2012-1-16///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 487///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-5860-01A-01R-1653-07///unique_patient_id: TCGA-CM-5860"
"TCGA-CM-6166-01A-11R-1653-07"	"TCGA-CM-6166"	"TCGA-CM-6166-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	48	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	33	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 48///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: aedde4a5-6520-40b9-9721-c9b826490b7a///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -17807///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 153///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Not Expressed|PMS2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 33///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6166///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 45///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 05ba0157-4b44-4740-8100-69f7a4b52422///date_of_form_completion: 2012-2-13///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 668///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6166-01A-11R-1653-07///unique_patient_id: TCGA-CM-6166"
"TCGA-CK-5916-01A-11R-1653-07"	"TCGA-CK-5916"	"TCGA-CK-5916-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"early"	"0"	"0"	"0"	NA	71	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 71///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 38d65618-4857-490e-86b3-0a3f772a9f60///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -26023///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T0///pathologic_stage: Stage I///patient_id: 5916///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 3.2///primary_lymph_node_presentation_assessment: NA///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2003///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-CK-5916-01A-11R-1653-07///unique_patient_id: TCGA-CK-5916"
"TCGA-CM-5862-01A-01R-1653-07"	"TCGA-CM-5862"	"TCGA-CM-5862-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	80	NA	"norecurrence"	153	"deceased"	NA	NA	"ascending"	"r"	"m"	"wt"	NA	NA	NA	NA	24	1	"4"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: a19cd9f8-482b-4b70-b7d7-06d6bb1b0260///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -29492///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 162.5///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1a///pathologic_N: N1a///pathologic_T: T3///pathologic_stage: Stage IVA///patient_id: 5862///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 10///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: YES///weight: 77.6///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: cf8ef37d-9f03-41ee-a49e-e2daaa280252///date_of_form_completion: 2012-1-16///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 153///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-CM-5862-01A-01R-1653-07///unique_patient_id: TCGA-CM-5862"
"TCGA-A6-5666-01A-01R-1653-07"	"TCGA-A6-5666"	"TCGA-A6-5666-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"late"	"4"	"0"	"0"	NA	78	509	"recurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	30	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 25c3201a-3dd5-4edf-ad09-104e5c10663e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -28514///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 193///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 30///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T4b///pathologic_stage: Stage IIC///patient_id: 5666///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 3.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 95.4///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: 0625FDB0-ACC7-413E-B950-5E4D7CF8D1B7///date_of_form_completion: 2012-5-21///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 719///days_to_new_tumor_event_after_initial_treatment: 509///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-5666-01A-01R-1653-07///unique_patient_id: TCGA-A6-5666"
"TCGA-F4-6856-01A-11R-1928-07"	"TCGA-F4-6856"	"TCGA-F4-6856-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	45	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	21	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 45///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 64bd568d-0509-48fe-8d0a-aef2a85d5c57///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -16519///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 160///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6856///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 61///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-F4-6856-01A-11R-1928-07///unique_patient_id: TCGA-F4-6856"
"TCGA-G4-6304-01A-11R-1928-07"	"TCGA-G4-6304"	"TCGA-G4-6304-01A-11R-1928-07"	"tumor"	"co"	NA	NA	"late"	"4"	"0"	"0"	NA	66	859	"recurrence"	NA	"living"	NA	NA	"transverse"	"r"	"f"	NA	NA	NA	NA	NA	25	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 66///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 567ddc8e-2b00-417d-a326-479cb02e08dd///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -24172///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 25///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T4///pathologic_stage: Stage IIB///patient_id: 6304///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 4.4///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 57///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: YES///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: bd0b5c0b-747f-4aa4-936d-8b4165073514///date_of_form_completion: 2012-2-6///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1631///days_to_new_tumor_event_after_initial_treatment: 859///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6304-01A-11R-1928-07///unique_patient_id: TCGA-G4-6304"
"TCGA-CK-5915-01A-11R-1653-07"	"TCGA-CK-5915"	"TCGA-CK-5915-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"late"	"2"	"0"	"X"	NA	63	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 63///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: c658f35d-ceeb-4189-8e3d-03e3b9706667///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -23040///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 5915///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NA///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CK///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-CK-5915-01A-11R-1653-07///unique_patient_id: TCGA-CK-5915"
"TCGA-CM-5861-01A-01R-1653-07"	"TCGA-CM-5861"	"TCGA-CM-5861-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	63	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	28	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 63///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 9743d31a-ea8f-4847-87d2-ebf77cc5983d///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -23252///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 164///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 28///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5861///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 3.2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 122///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: c2467273-6794-4b2f-9fe3-6f8a23b4a97b///date_of_form_completion: 2012-1-16///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 457///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-5861-01A-01R-1653-07///unique_patient_id: TCGA-CM-5861"
"TCGA-CA-5796-01A-01R-1653-07"	"TCGA-CA-5796"	"TCGA-CA-5796-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	52	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 52///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 65ab030d-39f2-48ab-80ac-90cb1faa823a///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -19353///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5796///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CA///tumor_tissue_site: Colon///venous_invasion: NA///weight: NA///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 6b8c57bf-a08b-4dd1-a462-d20602837e61///date_of_form_completion: 2012-1-9///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 99///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CA-5796-01A-01R-1653-07///unique_patient_id: TCGA-CA-5796"
"TCGA-A6-5661-01A-01R-1653-07"	"TCGA-A6-5661"	"TCGA-A6-5661-01A-01R-1653-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	80	NA	"norecurrence"	NA	"living"	NA	"MSI"	"ascending"	"r"	"f"	NA	NA	NA	NA	NA	21	0	"2"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 80///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 4beee9d4-ee52-4fed-bcc4-d300f5ddd4d0///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -29446///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 170///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Expressed|PMS2 Not Expressed|MSH6 Expressed///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: YES///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 5///number_of_first_degree_relatives_with_cancer_diagnosis: 2///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 5661///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 4.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 69.1///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 4597b875-a4a6-4c87-9d2e-bf4b05f03c69///date_of_form_completion: 2011-5-27///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 306///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-A6-5661-01A-01R-1653-07///unique_patient_id: TCGA-A6-5661"
"TCGA-CM-6167-01A-11R-1653-07"	"TCGA-CM-6167"	"TCGA-CM-6167-01A-11R-1653-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	57	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	40	11	"3"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 57///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: d42bc7f0-cfb2-4ece-ae47-521308635633///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -21030///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 174///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Not Expressed|PMS2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 40///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 11///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2b///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 6167///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 5.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: YES///weight: 89///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 6fb6c411-1bc7-4a1f-8cdb-432cee3304b2///date_of_form_completion: 2012-2-13///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 456///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-6167-01A-11R-1653-07///unique_patient_id: TCGA-CM-6167"
"TCGA-AZ-6607-01A-11R-1839-07"	"TCGA-AZ-6607"	"TCGA-AZ-6607-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"4"	"2"	"1"	NA	69	NA	NA	NA	NA	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	19	5	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 64dcf1a5-c78c-4d3f-852c-15865b3b6189///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -25448///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N2///pathologic_T: T4///pathologic_stage: Stage IV///patient_id: 6607///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 22.6///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AZ///tumor_tissue_site: Colon///venous_invasion: YES///weight: NA///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AZ-6607-01A-11R-1839-07///unique_patient_id: TCGA-AZ-6607"
"TCGA-CA-6719-01A-11R-1839-07"	"TCGA-CA-6719"	"TCGA-CA-6719-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	77	NA	NA	NA	NA	NA	NA	"descending"	"l"	"m"	NA	NA	NA	NA	NA	NA	NA	"2"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: 9cdca5d8-ea77-4df9-b2ba-0d5e8ec37bcd///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28343///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 172///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6719///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: ASIAN///residual_tumor: RX///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: CA///tumor_tissue_site: Colon///venous_invasion: NA///weight: 61///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-CA-6719-01A-11R-1839-07///unique_patient_id: TCGA-CA-6719"
"TCGA-CM-6675-01A-11R-1839-07"	"TCGA-CM-6675"	"TCGA-CM-6675-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"1"	NA	35	337	"recurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	72	12	"4"	"black"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 35///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: fce1fd5a-54d2-4260-b187-4eb7035e96e9///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -12935///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 187///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Not Expressed|PMS2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 72///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 12///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1b///pathologic_N: N2b///pathologic_T: T3///pathologic_stage: Stage IVB///patient_id: 6675///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: YES///weight: 93.9///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: 2d5dcdd9-0ad5-4b23-b1a0-c75fd3a3642d///date_of_form_completion: 2012-4-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 396///days_to_new_tumor_event_after_initial_treatment: 337///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-6675-01A-11R-1839-07///unique_patient_id: TCGA-CM-6675"
"TCGA-CM-6677-01A-11R-1839-07"	"TCGA-CM-6677"	"TCGA-CM-6677-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	75	NA	"norecurrence"	NA	"living"	NA	NA	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	20	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 75///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: a85e8208-a6f5-4e91-8f35-ef574f4273fc///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -27575///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 167///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 20///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6677///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 3.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 99.5///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: df35fb6a-9e5c-49e1-ab44-d38a48f89409///date_of_form_completion: 2012-4-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 337///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6677-01A-11R-1839-07///unique_patient_id: TCGA-CM-6677"
"TCGA-CM-6678-01A-11R-1839-07"	"TCGA-CM-6678"	"TCGA-CM-6678-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"4"	"1"	"1"	NA	63	0	"recurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"f"	"mutant"	NA	NA	NA	NA	19	0	"4"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 63///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: d7048098-09b3-4763-ad54-9c5c6fe14bc0///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -23069///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 157///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: 12///kras_mutation_found: YES///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1a///pathologic_N: N1c///pathologic_T: T4a///pathologic_stage: Stage IVA///patient_id: 6678///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 286.6///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 59///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: YES///bcr_followup_uuid: 78200de2-0c2f-40cc-a6bd-d7dc7f331ada///date_of_form_completion: 2012-4-19///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: 244///days_to_death: NA///days_to_last_followup: 335///days_to_new_tumor_event_after_initial_treatment: 0///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: Liver///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-CM-6678-01A-11R-1839-07///unique_patient_id: TCGA-CM-6678"
"TCGA-CM-6679-01A-11R-1839-07"	"TCGA-CM-6679"	"TCGA-CM-6679-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	58	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	21	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 58///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 76e96b5a-b565-42c7-a651-34d5132e6dde///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 40///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21519///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 178///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Not Expressed|MSH2 Not Expressed|PMS2 Not Expressed|MSH6 Not Expressed///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6679///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.3///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 106.5///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 571f10bd-e55b-46df-876c-d0ddf7d0bc5a///date_of_form_completion: 2012-4-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 306///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6679-01A-11R-1839-07///unique_patient_id: TCGA-CM-6679"
"TCGA-F4-6703-01A-11R-1839-07"	"TCGA-F4-6703"	"TCGA-F4-6703-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	64	NA	"norecurrence"	NA	"living"	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	12	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 64///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 0c53b010-4243-4da3-a059-7f54c9a850ec///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -23644///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 172///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NA///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6703///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 84///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: EBF95463-1390-47D2-B36C-2CA8AA7F00EC///date_of_form_completion: 2012-4-24///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 298///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-F4-6703-01A-11R-1839-07///unique_patient_id: TCGA-F4-6703"
"TCGA-F4-6704-01A-11R-1839-07"	"TCGA-F4-6704"	"TCGA-F4-6704-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"X"	NA	60	NA	NA	NA	NA	NA	"MSS"	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	18	13	"3"	"other"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 60///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: c6ed47f4-358b-4f06-b5cd-cdf1d5c47b43///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21949///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 183///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 18///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 13///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N2b///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 6704///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 14.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: AMERICAN INDIAN OR ALASKA NATIVE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 163///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-F4-6704-01A-11R-1839-07///unique_patient_id: TCGA-F4-6704"
"TCGA-F4-6805-01A-11R-1839-07"	"TCGA-F4-6805"	"TCGA-F4-6805-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	58	NA	NA	NA	NA	NA	NA	"descending"	"l"	"f"	NA	NA	NA	NA	NA	NA	NA	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 58///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: e76258b7-e13a-4b05-855b-d792701ffba1///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21241///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 162///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: NA///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: NA///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6805///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: NO///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 60///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-F4-6805-01A-11R-1839-07///unique_patient_id: TCGA-F4-6805"
"TCGA-F4-6806-01A-11R-1839-07"	"TCGA-F4-6806"	"TCGA-F4-6806-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	59	NA	NA	NA	NA	NA	"MSS"	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	5	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 59///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: bab21810-f51b-421e-a87f-1f1136cbc77a///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -21624///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 172///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 5///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: 0///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6806///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 70///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-F4-6806-01A-11R-1839-07///unique_patient_id: TCGA-F4-6806"
"TCGA-F4-6807-01A-11R-1839-07"	"TCGA-F4-6807"	"TCGA-F4-6807-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	51	NA	NA	NA	NA	NA	"MSS"	"hepaticflexure"	"r"	"f"	NA	NA	NA	NA	NA	12	12	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 51///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 9382987c-b5b3-48fe-8194-4d83fe340cd0///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -18690///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 166///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: 0///number_of_lymphnodes_positive_by_he: 12///number_of_lymphnodes_positive_by_ihc: 12///pathologic_M: M0///pathologic_N: N2b///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 6807///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 57///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-F4-6807-01A-11R-1839-07///unique_patient_id: TCGA-F4-6807"
"TCGA-F4-6808-01A-11R-1839-07"	"TCGA-F4-6808"	"TCGA-F4-6808-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"1"	"0"	"0"	NA	54	NA	NA	NA	NA	NA	"MSS"	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	3	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 54///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 4a785dc7-f5f6-4607-a19d-e6354b2fb5a9///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -19802///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 166///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 3///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: 0///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T1///pathologic_stage: Stage I///patient_id: 6808///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 70///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-F4-6808-01A-11R-1839-07///unique_patient_id: TCGA-F4-6808"
"TCGA-F4-6809-01A-11R-1839-07"	"TCGA-F4-6809"	"TCGA-F4-6809-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	52	NA	"norecurrence"	402	"deceased"	NA	NA	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	12	3	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 52///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: e7af286b-3dec-4cf2-8fbd-fa64b3efdf7f///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -19039///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 150///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 12///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 3///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IVA///patient_id: 6809///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: F4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 88///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: F13A8E30-9361-4847-BC94-78EBB5A83C83///date_of_form_completion: 2012-5-8///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 402///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-F4-6809-01A-11R-1839-07///unique_patient_id: TCGA-F4-6809"
"TCGA-G4-6309-01A-21R-1839-07"	"TCGA-G4-6309"	"TCGA-G4-6309-01A-21R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	40	NA	"norecurrence"	NA	"living"	NA	"MSI"	"sigmoid"	"l"	"f"	NA	NA	NA	NA	NA	24	2	"3"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 40///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: e4be17c8-0855-432c-bb80-28bb24b62f32///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -14729///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 176///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Not Expressed|MSH6 Expressed///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: YES///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6309///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 65.4///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: f271a489-f64b-4e61-8b65-af850ac0e6d4///date_of_form_completion: 2012-1-7///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1574///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6309-01A-21R-1839-07///unique_patient_id: TCGA-G4-6309"
"TCGA-G4-6628-01A-11R-1839-07"	"TCGA-G4-6628"	"TCGA-G4-6628-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"early"	"2"	"0"	"0"	NA	78	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	16	0	"1"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 2c0a725a-e829-4d84-89d9-d0d47f6cfa37///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -28772///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 169///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T2///pathologic_stage: Stage I///patient_id: 6628///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2.1///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 91///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 423dcf39-cb1b-4698-87a8-1a3d818145cf///date_of_form_completion: 2012-2-7///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1594///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-G4-6628-01A-11R-1839-07///unique_patient_id: TCGA-G4-6628"
"TCGA-A6-6137-01A-11R-1774-07"	"TCGA-A6-6137"	"TCGA-A6-6137-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	55	NA	"norecurrence"	NA	"living"	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	21	0	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 55///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 326c1637-ea91-4006-b440-d38420af1ae5///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -20095///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 180.3///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1c///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6137///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 93///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: a37c30e7-467e-4fb3-8336-9cc8aeaa8e11///date_of_form_completion: 2011-11-3///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 348///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-6137-01A-11R-1774-07///unique_patient_id: TCGA-A6-6137"
"TCGA-A6-6648-01A-11R-1774-07"	"TCGA-A6-6648"	"TCGA-A6-6648-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"0"	"1"	NA	56	NA	"norecurrence"	NA	"living"	NA	"MSS"	"transverse"	"r"	"m"	"wt"	NA	NA	NA	NA	21	0	"4"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"age_at_initial_pathologic_diagnosis: 56///anatomic_neoplasm_subdivision: Transverse Colon///b_symptoms: NA///bcr_patient_uuid: 65056295-8fcd-4f82-a3c9-a5acd79521fe///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -20640///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 182.8///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 21///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1a///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IVA///patient_id: 6648///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 2.5///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: NO///weight: 87///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: e118640d-684b-463e-a65f-8a16cfde6344///date_of_form_completion: 2011-11-1///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 344///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-6648-01A-11R-1774-07///unique_patient_id: TCGA-A6-6648"
"TCGA-A6-6649-01A-11R-1774-07"	"TCGA-A6-6649"	"TCGA-A6-6649-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	66	NA	"norecurrence"	NA	"living"	NA	NA	"hepaticflexure"	"r"	"m"	NA	NA	NA	NA	NA	23	2	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 66///anatomic_neoplasm_subdivision: Hepatic Flexure///b_symptoms: NA///bcr_patient_uuid: 39b6ae01-c97b-4234-8a28-208fdf170432///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -24237///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 190///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 23///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1b///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6649///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 10.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: A6///tumor_tissue_site: Colon///venous_invasion: YES///weight: 106///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 94a3ae6f-1301-4a8f-8cc1-bccc72c5b005///date_of_form_completion: 2011-12-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 328///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-A6-6649-01A-11R-1774-07///unique_patient_id: TCGA-A6-6649"
"TCGA-AA-3518-11A-01R-1672-07"	"TCGA-AA-3518"	"TCGA-AA-3518-11A-01R-1672-07"	"adjacentnormal"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	81	NA	NA	NA	NA	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	27	0	"2"	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 81///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: c5c4a0a5-900d-483d-9282-475654d63265///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -29769///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NA///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: YES///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 27///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 3518///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: 1.48///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: NA///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: AA///tumor_tissue_site: Colon///venous_invasion: NO///weight: NA///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-AA-3518-11A-01R-1672-07///unique_patient_id: TCGA-AA-3518"
"TCGA-CM-6680-01A-11R-1839-07"	"TCGA-CM-6680"	"TCGA-CM-6680-01A-11R-1839-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	78	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"f"	NA	NA	NA	NA	NA	17	4	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 78///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: fb9e7684-a7f7-4f17-bc5d-1f359e1b0d42///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -28701///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 150///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 4///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2a///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6680///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: CM///tumor_tissue_site: Colon///venous_invasion: NO///weight: 72.4///year_of_initial_pathologic_diagnosis: 2011///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 90c1e683-5170-4341-84a1-6d89b7456cd3///date_of_form_completion: 2012-4-18///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 366///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-CM-6680-01A-11R-1839-07///unique_patient_id: TCGA-CM-6680"
"TCGA-D5-6529-01A-11R-1774-07"	"TCGA-D5-6529"	"TCGA-D5-6529-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	69	386	"recurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	19	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 9c34830b-4d7f-4b41-9659-fbfc36c145c9///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 50///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25393///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 176///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 19///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6529///perineural_invasion_present: YES///preoperative_pretreatment_cea_level: 8.4///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 7th///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 106///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: e5a41cd8-0a19-47b5-821d-d6db0345375e///date_of_form_completion: 2012-3-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 614///days_to_new_tumor_event_after_initial_treatment: 386///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: Liver///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6529-01A-11R-1774-07///unique_patient_id: TCGA-D5-6529"
"TCGA-D5-6532-01A-11R-1723-07"	"TCGA-D5-6532"	"TCGA-D5-6532-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	61	NA	"norecurrence"	NA	"living"	NA	NA	"sigmoid"	"l"	"m"	NA	NA	NA	NA	NA	10	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 61///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: ac13d568-f79e-4ba7-b7bf-18e4354e0920///braf_gene_analysis_performed: NA///braf_gene_analysis_result: NA///circumferential_resection_margin: 10///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -22344///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 174///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 10///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6532///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.7///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: NA///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 92///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 20ad0e10-8b26-4e04-afa5-99b9f2f686ef///date_of_form_completion: 2012-2-27///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 555///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6532-01A-11R-1723-07///unique_patient_id: TCGA-D5-6532"
"TCGA-D5-6541-01A-11R-1723-07"	"TCGA-D5-6541"	"TCGA-D5-6541-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	49	NA	"norecurrence"	NA	"living"	NA	NA	"splenicflexure"	"l"	"m"	NA	NA	NA	NA	NA	13	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 49///anatomic_neoplasm_subdivision: Splenic Flexure///b_symptoms: NA///bcr_patient_uuid: 39aec099-a33e-47a4-a602-cbf65ddd3830///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 30///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -18029///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 174///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 13///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: 0///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6541///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: D5///tumor_tissue_site: Colon///venous_invasion: NO///weight: 85///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 51177e35-3947-4f3c-88dc-2dbbfc7835c3///date_of_form_completion: 2012-2-27///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 474///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-D5-6541-01A-11R-1723-07///unique_patient_id: TCGA-D5-6541"
"TCGA-G4-6294-01A-11R-1774-07"	"TCGA-G4-6294"	"TCGA-G4-6294-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	75	517	"recurrence"	858	"deceased"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	10	2	"4"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 75///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 41f8c9fd-ae52-4458-886b-faf37de77dd0///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -27755///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 10///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 6294///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 47.5///year_of_initial_pathologic_diagnosis: 2004///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 62a43703-e6c3-4be9-83bd-d3d4e9e9d1b4///date_of_form_completion: 2012-2-21///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 858///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: 517///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Dead///Extract.Name: TCGA-G4-6294-01A-11R-1774-07///unique_patient_id: TCGA-G4-6294"
"TCGA-G4-6299-01A-11R-1774-07"	"TCGA-G4-6299"	"TCGA-G4-6299-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"2"	"0"	NA	69	NA	"norecurrence"	NA	"living"	NA	NA	"descending"	"l"	"m"	NA	NA	NA	NA	NA	17	8	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: 23252dca-e836-47a0-b294-758ad60aa259///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25317///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 130///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 17///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 8///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: 6299///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: YES///weight: 88///year_of_initial_pathologic_diagnosis: 2005///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: cb9fbe96-b7d6-4ab4-8c09-98fa666fc952///date_of_form_completion: 2012-1-20///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 2268///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6299-01A-11R-1774-07///unique_patient_id: TCGA-G4-6299"
"TCGA-G4-6303-01A-11R-1774-07"	"TCGA-G4-6303"	"TCGA-G4-6303-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"1"	NA	54	872	"recurrence"	2003	"deceased"	NA	NA	"sigmoid"	"l"	"f"	"wt"	NA	NA	NA	NA	25	1	"4"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 54///anatomic_neoplasm_subdivision: Sigmoid Colon///b_symptoms: NA///bcr_patient_uuid: 264c0d45-078a-4207-a101-71f99bcd237e///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -19799///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 25///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: YES///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M1///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IV///patient_id: 6303///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 3.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: YES///weight: 69///year_of_initial_pathologic_diagnosis: 2006///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: b4f1d500-2d0c-4ab4-8ec2-d35eb74d483f///date_of_form_completion: 2012-1-20///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 2003///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: 872///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Dead///Extract.Name: TCGA-G4-6303-01A-11R-1774-07///unique_patient_id: TCGA-G4-6303"
"TCGA-G4-6310-01A-11R-1723-07"	"TCGA-G4-6310"	"TCGA-G4-6310-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"0"	NA	69	NA	"norecurrence"	NA	"living"	NA	"MSS"	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	66	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 69///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 14c13b05-abfe-472e-83a9-b28f60e58ad8///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 8///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -25243///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 173///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: YES///loss_expression_of_mismatch_repair_proteins_by_ihc_result: MLH1 Expressed|MSH2 Expressed|PMS2 Expressed|MSH6 Expressed///lymph_node_examined_count: 66///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6310///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: Yes///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: YES///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 102.5///year_of_initial_pathologic_diagnosis: 2008///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 3d26dfa2-5342-49fc-9e8c-67fb064d7cfa///date_of_form_completion: 2012-1-25///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1372///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: YES///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6310-01A-11R-1723-07///unique_patient_id: TCGA-G4-6310"
"TCGA-G4-6322-01A-11R-1723-07"	"TCGA-G4-6322"	"TCGA-G4-6322-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"3"	"1"	"X"	NA	65	789	"recurrence"	NA	"living"	NA	NA	"descending"	"l"	"m"	NA	NA	NA	NA	NA	26	2	"3"	"caucasian"	NA	NA	NA	NA	NA	"n"	NA	"n"	NA	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"n"	"y"	"n"	"age_at_initial_pathologic_diagnosis: 65///anatomic_neoplasm_subdivision: Descending Colon///b_symptoms: NA///bcr_patient_uuid: b3fea9bb-53f9-4ddb-922d-b570562d7a7d///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -23825///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 182///histological_type: Colon Mucinous Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 26///lymphatic_invasion: YES///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 2///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: 6322///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 4.2///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NA///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: YES///weight: 90.9///year_of_initial_pathologic_diagnosis: 2009///additional_pharmaceutical_therapy: NO///additional_radiation_therapy: NO///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NO///bcr_followup_uuid: b8500ee6-e106-4046-8c89-9ca1cab89d29///date_of_form_completion: 2012-2-21///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 792///days_to_new_tumor_event_after_initial_treatment: 789///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: WITH TUMOR///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: YES///vital_status: Alive///Extract.Name: TCGA-G4-6322-01A-11R-1723-07///unique_patient_id: TCGA-G4-6322"
"TCGA-G4-6323-01A-11R-1723-07"	"TCGA-G4-6323"	"TCGA-G4-6323-01A-11R-1723-07"	"tumor"	"co"	NA	NA	"late"	"is"	"0"	"X"	NA	50	NA	"norecurrence"	NA	"living"	NA	NA	"caecum"	"r"	"m"	NA	NA	NA	NA	NA	24	0	"1"	"black"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 50///anatomic_neoplasm_subdivision: Cecum///b_symptoms: NA///bcr_patient_uuid: 0c463362-7925-4d9a-9d63-098b50af2fb9///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NO///days_to_birth: -18334///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 171.5///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 24///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: MX///pathologic_N: N0///pathologic_T: Tis///pathologic_stage: Stage IA///patient_id: 6323///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 0.9///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: BLACK OR AFRICAN AMERICAN///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 7th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 88.4///year_of_initial_pathologic_diagnosis: 2010///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: d0240b51-d0a9-464c-896a-930684fdd57a///date_of_form_completion: 2012-1-30///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 419///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-G4-6323-01A-11R-1723-07///unique_patient_id: TCGA-G4-6323"
"TCGA-G4-6627-01A-11R-1774-07"	"TCGA-G4-6627"	"TCGA-G4-6627-01A-11R-1774-07"	"tumor"	"co"	NA	NA	"early"	"3"	"0"	"0"	NA	84	1002	"recurrence"	NA	"living"	NA	NA	"ascending"	"r"	"m"	NA	NA	NA	NA	NA	16	0	"2"	"caucasian"	NA	NA	NA	NA	NA	"y"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 84///anatomic_neoplasm_subdivision: Ascending Colon///b_symptoms: NA///bcr_patient_uuid: 19089ae0-b590-4649-9d94-a147fa506e32///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: 6///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: YES///days_to_birth: -30697///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: NA///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: MALE///gleason_score: NA///height: 176///histological_type: Colon Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: NA///icd_o_3_histology: NA///icd_o_3_site: NA///informed_consent_verified: YES///kras_gene_analysis_performed: NO///kras_mutation_codon: NA///kras_mutation_found: NA///loss_expression_of_mismatch_repair_proteins_by_ihc: NO///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NA///non_nodal_tumor_deposits: NO///number_of_abnormal_loci: NA///number_of_first_degree_relatives_with_cancer_diagnosis: 1///number_of_loci_tested: NA///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: 6627///perineural_invasion_present: NO///preoperative_pretreatment_cea_level: 1.8///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: R0///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: 6th///tertiary_pattern: NA///tissue_source_site: G4///tumor_tissue_site: Colon///venous_invasion: NO///weight: 80///year_of_initial_pathologic_diagnosis: 2007///additional_pharmaceutical_therapy: YES///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 1ad40290-930c-4541-b61a-b5d2b8c00efe///date_of_form_completion: 2012-2-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 1434///days_to_new_tumor_event_after_initial_treatment: 1002///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: TUMOR FREE///radiation_therapy: NO///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NO///vital_status: Alive///Extract.Name: TCGA-G4-6627-01A-11R-1774-07///unique_patient_id: TCGA-G4-6627"
